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Abstract 
 This thesis has used ultra-high field (UHF) magnetic resonance imaging (MRI) to 
investigate the fundamental relationships between tissue microstructure and such 
susceptibility-based contrast parameters as the apparent transverse relaxation rate (R2*), 
the local Larmor frequency shift (LFS) and quantitative volume magnetic susceptibility 
(QS). The interaction of magnetic fields with biological tissues results in shifts in the LFS 
which can be used to distinguish underlying cellular architecture. The LFS is also linked 
to the relaxation properties of tissues in a gradient echo MRI sequence. Equally relevant, 
histological analysis has identified iron and myelin as two major sources of the LFS. As a 
result, computation of LFS and the associated volume magnetic susceptibility from MRI 
phase data may serve as a significant method for in vivo monitoring of changes in iron 
and myelin associated with normal, healthy aging, as well as neurological disease 
processes.  
 In this research, the cellular level underpinnings of the R2* and LFS signals were 
examined in a model rat brain system using 9.4 T MRI. The study was carried out using 
biophysical modeling and correlation with quantitative histology. For the first time, 
multiple biophysical modeling schemes were compared in both gray and white matter of 
excised rat brain tissue. Suprisingly, R2* dependence on tissue orientation has not been 
fully understood. Accordingly, scaling relations were derived for calculating the 
reversible, mesoscopic magnetic field component, R2′, of the apparent transverse 
relaxation rate from the orientation dependence in gray and white matter. Our results 
demonstrate that the orientation dependence of R2* and LFS in both white and cortical 
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gray matter has a sinusoidal dependence on tissue orientation and a linear dependence on 
the volume fraction of myelin in the tissue. 
 A susceptibility processing pipeline was also developed and applied to the 
calculation of phase-combined LFS and QS maps. The processing pipeline was 
subsequently used to monitor myelin and iron changes in multiple sclerosis (MS) patients 
compared to healthy, age and gender-matched controls. With the use of QS and R2* 
mapping, evidence of statistically significant increases in iron deposition in sub-cortical 
gray matter, as well as myelin degeneration along the white matter skeleton, were 
identified in MS patients. The magnetic susceptibility-based MRI methods were then 
employed as potential clinical biomarkers for disease severity monitoring of MS. It was 
demonstrated that the combined use of R2* and QS, obtained from multi-echo gradient 
echo MRI, could serve as an improved metric for monitoring both gray and white matter 
changes in early MS. 
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Scope of Thesis 
The following is a brief overview of each chapter contained in this thesis. Chapter One 
introduces the principles, methodologies and relevance of the research studies composing 
the thesis. The second chapter discusses the underlying background of MRI physics, 
signal acquisition and phase processing necessary for understanding relaxometry and 
susceptibility mapping. A processing pipeline for multi-echo, gradient echo-based 
quantification of tissue magnetic properties (R2*, LFS, and Δχ) is then examined in the 
third chapter.  
 Chapter Four derives from a manuscript published in the Proceedings of the 
National Academy of Sciences of the United States of America (Rudko et al., PNAS,     
Jan 7, 2014, 111(1), E159-167). It presents a fundamental research study utilizing 
combined R2*, LFS and QS mapping with multi-echo, gradient echo MRI at high field 
and ultra-high resolution. Multiple biophysical modeling schemes are compared for the 
first time in both gray and white matter for excised rat brain tissue. 
 Chapter Five derives from a manuscript accepted for publication in the journal, 
Radiology (Rudko et al., Radiology, manuscript #RAD-13-2475). It highlights a 7 T 
imaging study using whole-brain, quantitative Δχ and R2* mapping for simultaneous 
monitoring of iron deposition and demyelinating processes in MS patients. For the first 
time, voxel based morphometry is combined with generalized linear model (GLM) 
analysis to identify whole brain differences between patients and controls. The sixth and 
final chapter briefly summarizes the research carried out for this thesis. It also suggests 
ways of extending this research, with an emphasis on both technical developments and 
clinical applications. 
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Chapter 1 
Introduction  
The Prize is the pleasure of finding things out.  
– Richard Feynman, Quantum Man 
 
Over the last four decades, magnetic resonance imaging (MRI) has made dramatic 
progress as a non-invasive imaging modality for evaluating human tissue properties. 
Advanced technological breakthroughs in MRI now enable more accurate assessment of 
both the structure and function of many human organ systems.  Not only is MRI being 
used to diagnose a wide range of disease processes, it is also being applied to such 
diverse research areas as the study of heart valve abnormalities (1), functional brain 
activation (2) and autoimmune cell tracking (3). 
 Fundamentally, MRI uses a strong external magnetic field to generate a bulk 
magnetization in the hydrogen nuclei of the human body. When these nuclei are excited 
by a radiofrequency (RF) pulse, an MR signal can be detected by a receiver coil. By 
adding spatially-varying, linear magnetic field gradients, images can then be 
reconstructed which represent the radiofrequency signal emitted from tissues (4). For 
standard MRI techniques at clinical field strengths of 1.5 and 3 Tesla (T), the 
radiofrequency signal is primarily a measure of the nuclear magnetization properties of 
water protons. However, in ultra-high field MRI (UHF MRI, B0 ≥ 7 T), the interaction 
between the external magnetic field and the orbital electrons in biological molecules also 
leads to an appreciable increase in the Larmor resonance frequency experienced by water 
protons (5). This frequency perturbation can be related to the concentration of 
biomolecules (6-8) and serves as a useful, quantitative MRI (qMRI) biomarker. 
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 In any MRI scan, the specific physical characteristics of tissue being visualized 
depend on how the magnetic field is modulated during the acquisition process (9). Since 
the acquisition consists of a repetitive cycle of varying magnetic field gradients and RF 
pulses, the tissue magnetization undergoes a concomitant series of repetitive changes. 
Essentially, the magnetization is perturbed from its natural state and then allowed to 
recover to equilibrium through a process known as relaxation. This process provides the 
basic contrast in MRI. The differential relaxation rates of tissues result in relative signal 
differences observed in an image (10). In the section that follows, the sensitization of the 
MRI signal to different tissue relaxation properties is outlined in more detail and related 
to qMRI – a significant topic of discussion in this thesis. 
 
1.1 Sensitizing the MRI signal to tissue properties 
A pivotal improvement of MRI compared to other diagnostic imaging techniques such as 
x-ray computed tomography (CT), positron emission tomography (PET), ultrasound and 
optical imaging, is its ability to sensitize the signal to different properties of biological 
tissue (10). The MRI signal is flexible enough to reflect such biophysical quantities as 
tissue-specific nuclear relaxation rates (longitudinal relaxation rate: T1, transverse 
relaxation rate: T2, or effective transverse relaxation rate: T2*), rate of blood flow (11), 
blood oxygenation (12), water molecule self-diffusion (13), as well as tissue magnetic 
and electrical properties  (7, 14). 
 The T1 or T2–weighted contrast obtained in standard MRI methods is controlled 
through the adjustment of pulse sequence timing parameters such as the duration between 
successive radiofrequency (RF) pulses, or the flip angle of these pulses. This, in turn, 
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results in qualitative differences in signal intensity. For example, with an external 
magnetic field strength of 3 T, if contrast between gray and white matter in the human 
brain is desired, one can exploit the differences in either T1 (white matter = 1100 ms, gray 
matter = 1800 ms) or T2 (white matter = 70 ms , cortical gray matter = 100 ms) relaxation 
characteristics of brain tissue (15).  
 Because of its flexibility in generating contrast, MRI is used clinically by 
radiologists to confirm many soft tissue neurological disorders. However, the standard 
T1- and T2-weighted images employed by radiologists do not provide true quantitative 
metrics of tissue composition. They only identify relative differences in nuclear 
relaxation properties (4). This is problematic when seeking to relate the MRI signal to 
underlying cellular-level changes associated with either disease or normal, healthy aging. 
To make MRI more predictive of underlying biology, qMRI methods have been 
developed. For a qMRI parameter to be effective, it must be (i) reproducible, (ii) accurate 
and (iii) specific to underlying cellular architecture (16). Reproducibility reflects the 
magnitude of random errors that occur from one scan session to the next. Generally, these 
should be significantly less than the natural variation of the qMRI parameter itself. 
Accuracy reflects how closely a measurement is to the true value. Specificity reflects how 
closely the change in the qMRI parameter reflects the change in biology of the tissue. 
 Two frequently employed qMRI techniques are T1 and T2 relaxometry (16). With 
these two methods, specific magnetic field gradients and RF pulse combinations are used 
to probe the relaxation of nuclear magnetization over time. A quantitative value of T1 or 
T2 can then be assigned to each location in the brain. Relaxometry has proven valuable in 
understanding such neurological conditions as cerebral edema (17), Alzheimer’s and 
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multiple sclerosis (MS) (18). However, T1 and T2  relaxometry require long acquisition 
times and are usually not suitable for whole-brain imaging.  
 This thesis examines the use of three magnetic susceptibility-based qMRI 
parameters acquired using a time-efficient, multi-echo, gradient echo sequence: apparent 
transverse relaxation rate (R2*), local Larmor frequency shift (LFS) and volume magnetic 
susceptibility (∆χ). In all computations, standard error analysis methods are employed to 
identify accuracy. In the following section, the susceptibility-based MRI parameters are 
described in further detail. 
 
1.2 Ultra-High Field (UHF) MRI and its applications to susceptibility-induced 
contrast 
Currently, MRI scanners at high (≥ 3 T) and ultra high-field (UHF, ≥ 7 T) offer improved 
signal-to-noise ratio (SNR) and increased spatial resolution compared to standard clinical 
imaging at 1.5 T. UHF MRI allows visualization of smaller structures in the human brain, 
including cortical folding patterns (19) and venous vasculature organization (20). A 
further advantage of UHF MRI is its increased magnetic susceptibility contrast, 
particularly useful in functional MRI (fMRI) (21) and superparamagnetic iron-oxide 
nano-particle (SPIO) tracking (22-24). Such applications employ the magnitude of the 
complex MRI signal but disregard the phase. Recently however, it has been demonstrated 
that with proper processing, the contrast observed in the MRI phase is sensitive to 
relative concentration differences of such important biological substrates as myelin and 
iron (6, 25).  
 When the human body is exposed to a strong external magnetic field, small 
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differences in magnetic susceptibility between neighbouring tissues result in 
perturbations of the local magnetic field (26). These perturbations give rise to a 
detectable shift in the LFS, which is measurable through the complex image phase. 
Notably, the linear increase in magnetic susceptibility-induced field perturbations in UHF 
MRI results in higher signal-to-noise ratio (SNR) and improved contrast at higher B0 
fields for phase imaging (27). Once the image phase has been unwrapped and background 
magnetic field contributions have been removed, an estimate of tissue specific magnetic 
susceptibility properties may be computed (7, 28, 29). The magnetic susceptibility is 
calculated through a field-to-source inverse problem known as Quantitative Susceptibility 
Mapping (QSM), which reveals anatomical features in the brain with unprecedented 
quality. QSM also allows quantitative characterization of deep gray matter structures (7, 
30), brain tumours (31) , and sub-cortical iron increases in MS (32).   
 Presently, the clinical applicability of QSM is hampered by challenges associated 
with proper phase processing and interpretation of the QS signal (7). Numerical 
instabilities in the field-to-source inverse calculation can result in streaking or blurring 
artifacts which complicate quantitation (33). As well, the quality of QS maps critically 
depends on the accuracy of the measured image phase. Incorrect phase values due to 
blood flow, low SNR, or incomplete/inaccurate phase unwrapping produce significant 
non-local artifacts (6). Several solutions to these issues are addressed in this thesis, as 
well as the application of QSM in conjunction with R2* mapping to underlying tissue 
biology. Additionally, the clinical applicability for MS monitoring using combined 
whole-brain QS and R2* maps is described for the first time. 
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1.3 Application of UHF MRI to multiple sclerosis 
UHF, susceptibility-based MRI of multiple sclerosis constitutes one of the major chapters 
in this thesis. Accordingly, a brief overview follows of (i) the clinical symptoms and 
pathophysiology of MS and (ii) the clinical monitoring of MS using UHF MRI. 
1.3.1 Clinical symptoms and pathophysiology of MS 
 MS is a chronic, inflammatory disease of the central nervous system (CNS) 
characterized by a varied and unpredictable time course (34). It is the most common 
neurological disease affecting young adults in Canada (35, 36). Although the specific 
cause is unknown, it appears to involve both genetic susceptibility and triggers such as a 
virus, a dysregulated metabolism or environmental factors (37, 38). In most patients, MS 
consists of initial episodes of reversible neurological deficit followed by progressive 
deterioration, which can become severe and result in early death (34). Evolution of the 
disease produces a spectrum of clinical features that may include motor weakness, 
sensory and gait disturbances, vision loss and cognitive changes (34).  
 Several MS disease sub-types have been characterized. These are determined on 
the basis of such clinical criteria as frequency of relapses, time to disease progression, 
and lesion development (39). The major MS sub-types include: relapsing-remitting MS 
(RRMS, approximately 85% of cases), primary progressive MS (PPMS, approximately 
10% of cases) and progressive-relapsing MS (PRMS, about 5% of cases) (34). RRMS is 
characterized by unpredictable relapses followed by months to years of remission. A 
fourth major sub-type, secondary progressive MS (SPMS), occurs for approximately 65% 
of those with initial RRMS and is defined by a progressive neurologic decline between 
attacks without definite periods of remission (34). After initial symptoms, PPMS patients 
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experience no remission and symptoms steadily worsen (34). PPMS patients have steady 
neurologic decline from the onset, superimposed with attacks (34, 39).   
 The hallmark pathophysiology of MS is damage to myelin, axons and 
oligodendrocytes (37). This occurs through a multistep mechanism involving sequential 
inflammation, demyelination and neurodegeneration (34). The specific autoimmune 
targets are believed to be cellular components of the CNS normally inaccessible due to 
their location behind the blood–brain barrier. During disease initiation, entry of 
autoimmune cells (T-cells, B-cells and monocytes) through the blood brain barrier is 
triggered by cytokine and chemokine signals (37). Once within the CNS, T-cells are 
stimulated and retained there by resident microglia, which present antigen receptor sites 
to the T-cells. Microglia are also involved in clearing away myelin debris. This results in 
further T-cell/lymphocyte infiltration (34). Concurrent with the initial autoimmune 
response, the inflammatory infiltrate in white matter lesions eventually includes 
macrophages at the lesion centre. These are principally responsible for myelin digestion 
(37, 38). 
 The trigger for the T-cell mediated autoimmune attack in MS is unclear. 
However, it is recognized that MS consists of repeated attacks on both myelin and 
oligodendrocytes via an inflammatory cascade activated repeatedly over time. The 
existing knowledge of the interconnected cellular components in the cascade has already 
been used to create targeted therapies aimed at reducing progression (37, 40). From an 
MRI standpoint, targeted imaging of these cellular components utilizing, for example, 
iron-labeled cellular MRI (23), represents a promising avenue for monitoring critical 
components in the MS immune response. 
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1.3.2 UHF MRI of MS 
 
 Conventional MRI employing standard T1- and T2-weighted imaging plays a key 
role in diagnosing MS (41). However, neither lesion load or lesion volume derived from 
these standard sequences have correlated well with clinical symptoms and scoring scales 
(42). In addition, standard MRI findings have not demonstrated significant predictive 
power for identifying disease progression (39). Post-mortem histopathology has revealed 
the inability of standard MRI to visualize no more than a subset of the actual lesions and 
damage (43). 
 Standard MRI pulse sequences used for monitoring MS, such as T2-weighted fast 
spin echo (FSE) and fluid-attenuated inversion recovery (FLAIR), visualize only two-
thirds of histopathologically detectable white matter (WM) lesions and less than one-
tenth of cortical grey matter (GM) lesions (44). Moreover, the standard sequences are 
insensitive to damage in normal-appearing white matter, which is known to have a 
significant role in the onset of MS (45, 46). In contrast, susceptibility-based UHF MRI 
techniques, including the LFS and QS mapping methods detailed in this thesis, 
potentially offer more accurate visualization of early myelin changes in gray and white 
matter not visualized on standard MRI contrasts (6, 7). This is because QSM measures 
both the nuclear magnetization and the accompanying magnetic susceptibility in an 
imaging voxel (47). In white matter, these physical parameters are specific to the 
composition of myelin, since myelin is magnetized by an amount proportional to the 
magnetic susceptibility of phospholipid molecules in the myelin bilayers. Consequently, 
by using UHF MRI, QSM detects an intrinsic property that may be more closely linked 
to demyelination than such other methods as T2-based relaxometry or diffusion MRI 
measurements of fractional anisotropy. 
 Equally significant, depicting MS gray matter pathology using MRI directly 
relates to how clinicians deliver treatment. For example, the identification of gray matter 
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damage may serve as an improved biomarker for MS monitoring (48). Indeed, UHF T2*–
weighted MRI using 2D gradient echo imaging has already demonstrated an improved 
sensitivity for detecting gray matter lesions in vivo at 7 T (48). T2*–weighted MRI has 
also been used to monitor the accumulation of non-haeme iron in sub-cortical gray matter 
(30, 32, 49). Iron in sub-cortical gray matter is essential for normal neuronal metabolism, 
including mitochondrial energy generation and myelination. However, excessive levels 
may exert oxidative stress and result in cell death. When excess iron is present, 
incomplete chelation or storage results in iron catalyzing the production of hydroxyl 
radicals. The production of such radicals may trigger protein denaturation, damage to 
DNA or oxidation of phospholipid membranes (50). As result, monitoring the 
accumulation of non-haeme iron in the basal ganglia and linking this to clinical disability 
is a major area of interest in UHF MRI of MS. It is a primary focus in the fifth chapter of 
this thesis. 
  Several qMRI metrics, including T2, T2*, magnetic field correlation (MFC) and 
QSM have been proposed for monitoring basal ganglia iron in vivo. In this thesis, two of 
these metrics, T2* and QSM, are examined. Recent research has demonstrated that the 
apparent transverse relaxation rate (R2* = 1/ T2*) correlates well with basal ganglia iron 
(27). Regional values of R2* differ significantly between CIS patients (n = 32) and MS 
patients (n = 37) (51). This suggests R2* relaxometry may be a useful tool for evaluating 
differential iron deposition between MS disease groups. Further, it may prove helpful for 
clarifying whether regional iron accumulation contributes to MS pathology or merely 
reflects an epiphenomenon.  
 Recently, QSM has demonstrated an increased sensitivity to changes in iron 
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associated with normal aging (52) and MS (32) in basal ganglia structures compared to 
R2*. This increased sensitivity results from the ability of QS to measure the mean 
magnetic field perturbation in a voxel, as opposed to the signal relaxation of protons in 
water molecules (25). The mean magnetic field perturbation can then be directly linked to 
the amount of iron (52). However, relaxometric measures such as R2* are not specific to 
the mean magnetic field. Rather, they measure the effect of intra-voxel susceptibility 
gradients on phase dispersion of relaxing protons (53). In this thesis, the relative 
sensitivities of R2* and QS to iron accumulation in MS are evaluated as clinically relevant 
biomarkers.   
 The second chapter examines the underlying background of MRI physics, signal 
acquisition and phase processing necessary for understanding relaxometry and 
susceptibility mapping. For a complete overview of all chapters, refer to the ‘Scope of 
Thesis’ section on page xvii. 
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Chapter 2  
Underlying Sources of MRI Contrast and Signal Formation 
I canna’ change the laws of physics, Captain! 
– Scottie, head engineer in Star Trek 
 
To provide a brief background for the discussion of transverse relaxometry, LFS and QS 
mapping that follows, this chapter considers the fundamental sources of the MRI contrast 
and signal formation. It is partitioned into four sections. The first section describes the 
physics of MRI signal formation under the influence of a strong external magnetic field 
and radiofrequency (RF) pulse perturbations. The Bloch equations are then introduced as 
the mathematical model describing the time-evolution of the MRI signal. This is followed 
by a discussion of the basics of MR image reconstruction. Lastly, an introductory 
examination of susceptibility mapping provides a background for the phase processing 
pipeline presented in Chapter three. 
 
2.1 Underlying sources of the MRI signal 
In an external magnetic field such as the one produced by a superconducting MRI 
magnet, atomic nuclei can be treated as magnetic dipoles possessing a magnetic moment, 
µ, and an angular momentum, L. These two parameters are related accordingly (1): 
                          [2.1] 
where γ  is the gyromagnetic ratio which is specific to the nucleus of interest. The most 
common nucleus to be imaged in MRI is that of hydrogen bonded to oxygen in water. 
Hydrogen (H1) has a gyromagnetic ratio of  γ  = 267.51 × 106 radians/s/T  and contains a 
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single positively charged proton and a negatively charged electron bound by the Coulomb 
electromagnetic field (2). Under the influence of the external field of the MRI magnet, 
the proton experiences a torque (1), 
                                        [2.2] 
which can be related to the nuclear spin angular momentum by the equation (3):  
                                                                  [2.3]  
Equation [2.3] describes the time evolution of the nuclear magnetization (
  
M
→
) and forms 
the basis for the MRI Bloch equation - a first-order, linear differential equation describing 
the magnetization dynamics (3): 
                   
               
[2.4] 
In equation [2.4], Bext represents the combination of the static magnetic field and both the 
magnetic field gradients (G) and RF (B1) fields (4):  
                    
  
→
B ext = B0 k
∧
 +  γ G
→
⋅ r
→
k
∧
 +  B1x i
∧
 +  B1y j
∧
                     [2.5] 
Typically, the Bloch equation is written with respect to a particular reference frame, the 
most familiar of which is the frame rotating in relation to the z-axis of the scanner 
coordinate system at the Larmor frequency. In this frame, the external magnetic field 
becomes (4): 
                   
  
→
B rot =  
→
B ext − B0 k
∧
= γ G
→
⋅ r
→
k
∧
 +  B1x i
∧
 +  B1y j
∧
                 [2.6] 
Evaluating the Bloch equations in this reference frame is equivalent to stopping the free 
precession of spins in order to isolate the dynamics of the magnetization caused by RF  
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pulses and gradients.  The rotating reference frame is described pictorially as follows: 
 
Figure 2.1: (a) Classical representation of the nuclear magnetization vector, aligned 
along the magnetic field in the static reference frame. (b) Schematic representation of the 
reference rotating about the z-axis at the Larmor resonance frequency, (ω), of on-
resonant spins. 
 
The primed coordinates (x′, y′ and z′) in figure 2.1 indicate the axes are rotating about the 
z-axis at the Larmor frequency. During an MRI experiment, for signal to be detected by a 
receiver coil, the magnetization vector must be rotated into the transverse (x′y′) plane (3). 
This is accomplished through the application of an RF pulse (B1 field) which rotates the 
magnetization into the transverse plane by an angle θ = γ B1 t (4): 
 
Figure 2.2: Application of an RF pulse with flip angle θ = γ B1t along the x′-axis. For 
such an RF-pulse the magnetization vector, M, is rotated down along the y′-axis.  
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For modeling any real MRI experiment, this simplified pictorial description must be 
extended further to include the effects of magnetic fields produced by nuclear spins 
whose Larmor frequency is different from that of water (off-resonance spins) (1, 3). The 
magnetic field of these off-resonance spins, Boff, is not rotated into the transverse plane 
but does result in spins experiencing an effective field (Be) which is the vector sum of Boff 
and B1 (4). This concept is illustrated below:                    
           
Figure 2.3: Schematic representation of the magnetic field vectors applied in the rotating 
frame of reference (x′, y′, z′). The B1 magnetic field is applied at an angle φ relative to the 
x′-axis. Due to the presence of the magnetic field generated by off-resonance spins (Boff), 
the nuclear magnetization precesses around the effective magnetic field, Be, rather than 
the B1 field (1, 4, 5). The effective magnetic field is rotated away from the transverse 
plane by an angle ψ.  
 
Under the additional influence of T1 and T2 relaxation, the Bloch equation describing the 
dynamics of the magnetization vector can be re-written as (6-8): 
                                   [2.7] 
The first term on the right hand side of equation [2.7] accounts for the free precession of 
nuclei in the external magnetic field, as well as the effects of RF and gradient pulses. The 
second and third terms account for longitudinal recovery (T1) and transverse decay (T2) 
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respectively (8, 9). Equation [2.7] provides a phenomenological model of MRI spin 
precession and can be used to simulate the effects of an MRI pulse sequence numerically 
(10, 11). This is performed by inputting realistic values of T1, T2 and proton density and 
using standard numerical methods to express equation [2.7] in matrix form as follows:   
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[2.8] 
Equation [2.8], in discretized form, can be solved repeatedly for each repetition period in 
an MRI sequence by using a numerical simulation. Understanding the time-dependent 
changes in the nuclear magnetization vector plays a significant role in modeling the 
changes in both the magnitude and phase signal from white and gray matter in the brain – 
a major topic of discussion in this thesis.  
 
2.2 Signal detection and Fourier domain representation of the MR imaging 
experiment 
After the application of the RF pulse, the nuclear magnetization will precess in the 
transverse plane. The resultant time-varying magnetic field produced by the precessing 
magnetization generates a current in a receiver coil located in the vicinity of the sample. 
This current forms the basis for the MR image (3, 5). To more thoroughly understand this 
concept, consider the Fourier relationship between the time-varying current in the coil,  
s(t), and the Larmor resonance frequency, ω, of nuclei:  
       [2.9]
 For the hypothetical case of a sample consisting of only pure water, ignoring the effects 
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of nuclear relaxation, the Fourier relationship between the time-domain and Fourier 
domain signals can be visualized as follows: 
 
Figure 2.4: Ideal representation of the NMR signal for a sample containing pure water 
without T2-relaxation.  
  
The signal in the time domain oscillates at the Larmor frequency, while the 
corresponding frequency domain spectrum shows a peak at the Larmor frequency (5). In 
MRI of tissues in the human body, however, multiple chemical compounds exist in a 
single volume element (voxel) of the image. Each compound experiences a slightly 
different local magnetic field, resulting in a modified Fourier domain representation (9) 
that contains a spectrum of signals: 
 
Figure 2.5: Representation of the NMR signal for a sample containing compounds whose 
protons experience different local magnetic fields (magnetic environments) without       
T2-relaxation. The signal in the time domain is a composite sinusoid that oscillates at a 
frequency that is the sum of the frequencies of the nuclei in different chemical 
environments in the sample (3). The corresponding frequency domain spectrum displays 
multiple peaks – each of which represents a specific proton in a particular magnetic 
environment. 
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Furthermore, during any standard MRI pulse sequence, T2-based nuclear relaxation 
occurs (1, 12), resulting in an exponential decay of the signal, S(t). Here the variable "t" 
denotes the time after the RF pulse. The exponential decay of the signal in the time 
domain corresponds to a line-broadening of the signal in the Fourier domain (1) as 
illustrated below:       
 
Figure 2.6: NMR signal for a sample of pure water subject to T2-relaxation. This results 
in exponential decay of the time domain signal, S(t). The line shape of the frequency 
domain signal is broadened due to the exponential T2-decay process. In the simplified 
representation above, the contributions of multiple resonating species with different 
Larmor frequencies are neglected.  
 
To spatially discriminate the frequency domain signal, S(ω), at one voxel from other 
voxels in an image, MRI employs linear, magnetic field gradients to modulate the 
amplitude of the main magnetic field (1, 12, 13). Linear modulation of the main magnetic 
field (B0) enables the assignment of a unique resonance frequency to each location in the 
image space. The magnetic gradient field, G, is generated by a current carrying wire 
wound into a solenoid which produces a linear magnetic field variation along the 
direction of the main field according to the following equation: 
                     [2.10] 
The application of this gradient results in the Larmor resonance frequency of spins  
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becoming proportional to their spatial location: 
               [2.11] 
Through the linear relationship in equation [2.11] the desired amplitude of the gradient 
field, G, can be calculated for a particular pulse bandwidth, with Δω representing the 
range of frequencies excited by the RF pulse (1, 5, 13). For instance, for a gradient 
amplitude of Gz and a desired slice thickness, ΔZ , the relationship between the spatial 
location of a slice and its Larmor frequency is depicted as follows: 
              
Figure 2.7: Linear relationship between z-dimension slice thickness (ΔZ) of an MRI 
pulse sequence and the bandwidth of the RF pulse (Δω).   
 
 The MRI signal detected at a time "t" after the radiofrequency excitation pulse in 
the presence of an imaging gradient is then related to the nuclear spin density by the  
following Fourier relationship (12): 
  
S(t) = ρ ( r
→
−∞
∞
∫ ) eiω ( r
→
)td r
→
     [2.12]
 
where ρ(
  
r
→
) represents the spin density of nuclei at a particular location. In the rotating 
reference frame, where the Larmor frequency is removed from the signal, equation [2.12]  
is expressed as: 
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  
S(t) = ρ ( r
→
−∞
∞
∫ ) eiγ G r
→
td r
→
    [2.13]  
To express this equation in more compact form, the relationship in equation [2.13] can be  
 
simplified (1, 5). The following change of variables is customary:  
              [2.14] 
which, for the case of temporally-varying gradient waveforms, becomes: 
         [2.15] 
where equation [2.15] defines the signal in the spatial frequency domain (often referred to 
as k-space in MRI). The spatial frequency domain signal is related to the spin density          
(ρ(r)), which is the variable of interest in MRI, through the inverse Fourier transform 
operation: 
     [2.16] 
From equation [2.16], it is clear that the relationship between the frequency domain 
signal and MRI and the spatial domain spin density is through use of the inverse Fourier 
transform. This relationship is represented schematically below: 
       
Figure 2.8: Fourier relationships between the frequency domain signal and the image 
space signal in MRI.   
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The position at each point in k-space is related to the degree of image contrast variation at 
a particular frequency (12). The center-most regions of k-space contain information about 
the low spatial frequency components of the image. The outer-most regions of k-space 
contain information about the high spatial frequency components of the image. 
 
2.3 Gradient recalled echo imaging and T2* contrast 
Gradient recalled echo (GRE) imaging is the preferred method for acquiring complex, 
T2*-weighted data used to isolate the image phase for LFS and QS mapping (14, 15). 
GRE methods encompass a relatively large class of MRI pulse sequences that do not use 
spin echoes (16). They include gradient-spoiled, RF-spoiled and balanced steady-state 
free precession (bSSFP) sequences (17). A standard, gradient-spoiled GRE sequence 
typically consists of an RF excitation, followed by imaging gradients and data 
acquisition. The sequence is repeated many times to acquire a full imaging volume. 
 
Figure 2.9: Pulse sequence diagram illustrating a typical gradient echo imaging sequence 
used in susceptibility mapping at UHF. 
 
In figure 2.9, the echo time (TE) represents the time between the RF excitation and the 
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middle of the readout gradient. The value of TE, along with the repetition interval (TR), 
flip angle and spoiling method, all influence the signal in a GRE sequence. The contrast 
is also influenced by the T1, T2 and T2* properties of the tissue (17). For example, when 
the TR period is reduced below approximately 2 × T1, the spins do not regain complete 
longitudinal magnetization following the excitation pulse and a steady-state 
magnetization is reached (14, 18). In such a steady-state, the regrowth of the longitudinal 
magnetization is in equilibrium with the reduction in this magnetization caused by the RF 
pulse.   
 If GRE imaging is preferentially sensitized to the T2* relaxation rate (R2* = 1/T2*), 
an image is obtained which is dominated by two parameters:(i) the rate of apparent signal 
decay in an imaging voxel produced by spin-spin (R2 = 1/T2) dephasing of the transverse 
magnetization (Mxy) and (ii) local magnetic field inhomogeneities (R2′ = 1/T2′) (19).  
         R2* = R2  + R2′            [2.17] 
Mathematically, the influence of R2* on the time-dependent MRI signal, S(t), in a GRE 
experiment can be understood using the static dephasing regime theory (20). In this 
regime, self-diffusion of water molecules is neglected and the MRI signal, normalized to 
the voxel volume, is given by:                                   
      
  
  
S(t) = 1V ⋅ ρ ⋅ d 
 r 
V0
∫ ⋅ exp(−t ⋅R2 (
 r )) ⋅ exp(−i ⋅ω ( r ) ⋅ t)     [2.18] 
where ρ represents the combined effects of spin density, receiver coil sensitivity and RF 
excitation efficiency. The   
  
exp(−t ⋅R2 (
 r ))
 
term is proportional to the influence of R2 at a 
point   
  
 r  in the medium. The   
  
exp(−i ⋅ω ( r ) ⋅ t)  term is proportional to the influence of R2′ at 
a point   
  
 r  in the medium and is dependent upon the geometry of the microscopic 
perturbers (21).  The value of the relaxation constant in a tissue can be derived from Eq. 
[2.18] by integrating  over the volume of interest and performing a non-linear, least 
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squares fit to the resulting function: 
                   [2.19] 
where S0 represents the magnitude signal immediately after the RF pulse was applied and 
t represents the time from the centre of the RF pulse to the center of the readout window. 
This is schematically displayed in figure 2.10: 
                                          
 
Figure 2.10: Schematic representation of a single repetition period for a multi-echo, GRE 
sequence. The α symbols denote the excitation pulses The fitted signal decay (red curve) 
corresponding to equation [2.19] and corresponding measurements points (black dots) are 
overlaid on the bipolar readout gradient diagram.    
 
  
GRE methods are particularly useful for fast, whole brain imaging because they 
employ small RF pulse flip angles and shorter repetition times compared to conventional, 
spin-echo sequences. Shorter TR periods result in an overall reduced acquisition time for 
volumetric imaging. Additionally, at UHF, radiofrequency heating mitigates the 
amplitude of the RF pulses that can be used. The low flip angles used in GRE imaging 
allows for rapid, whole-brain imaging with UHF MRI without significant tissue heating 
effects.  
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2.4 Susceptibility imaging using gradient echo MRI at UHF 
 Having outlined the foundations of GRE imaging, a brief description of 
electromagnetic theory applied to susceptibility processing now follows. This section 
focuses on the basic physics of susceptibility contrast in MRI. A more detailed discussion 
of processing and reconstruction techniques for susceptibility mapping is presented in     
Chapter 3. 
 The human body contains a range of magnetic susceptibility values. Soft tissue 
and bone are diamagnetically (negatively) shifted relative to water, with susceptibility 
values ranging from 0 to -30 parts per billion (ppb) of the main magnetic field (22). In 
contrast, iron and air are paramagnetically shifted relative to water, with susceptibility 
values ranging from ~ 40 to 400 ppb. The exact susceptibility distribution in the brain, 
however, is not known a priori (23). It is a function of tissue myelin, iron and protein 
content, as well as chemical exchange and the microscopic 
compartmentalization/geometry of water and lipid protons (24, 25). 
 To determine the susceptibility distribution in tissue, Maxwell’s equations are 
used. According to the theory of magnetostatics, a given susceptibility distribution, 
Δχ, produces a shift in the static magnetic field according to the Laplace equation (26): 
                  [2.20] 
The integral form of equation [2.20] can be written as: 
            [2.21] 
where ΔB( ) denotes the magnetic field shift and θrr′ is the angle produced by the 
projection of the long axis of the susceptibility inclusion onto the external magnetic field 
(27). For simple geometries, the solution to this convolution integral is obtained by using 
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a Green’s function expansion (28). From a practical standpoint, however, numerical 
computation of a solution to equation [2.21] is facilitated by transforming the integral 
relationship into the Fourier domain and implementing an iterative numerical solution 
(29). The resulting pointwise multiplication in the Fourier domain is given by:  
         
  
F (ΔB( r
→
)) = F (χ) × (13 −
kz2
k2
) = F (χ) × Fd ( k
→
)            [2.22] 
where F denotes the Fourier transform and Fd(k) represents the Fourier transform of the 
dipole convolution kernel (27). Essentially, the Fourier multiplication outlined in 
equation [2.22] works by assigning a single dipole to each imaging voxel in the LFS map. 
This significantly reduces the time required for the matrix inversion. However, the value 
of the Fourier convolution kernel, Fd(
  
k
→
) =  , is not defined for k = 0 (27, 29). 
The consequences of such a singularity, as well as methods for dealing with the 
coefficients where k = 0, are discussed further in Chapter 3.   
 Chapter 2 has focused on the fundamental concepts employed in QS mapping 
relevant to this thesis. Both QS mapping and the associated area of electromagnetic tissue 
properties mapping constitute relatively new areas of research having the potential for 
multiple future applications.  
 The development of a processing pipeline for multi-echo gradient-echo based 
quantification of tissue magnetic properties (R2*, LFS and Δχ) is discussed in Chapter 3. 
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Chapter 3  
Ultra-High Field MRI Susceptibility Processing 
The$answer$to$the$Great$Question$…$of$Life,$the$Universe$and$Everything$$
…$is$Forty;two.$$–!Douglas!Adams,!The$Hitchhiker’s$Guide$to$the$Galaxy$
 
3.1 Human brain tissue magnetic properties mapping using ultra-high field 
MRI 
Bulk magnetic susceptibility has long been utilized in MRI as a clinically relevant 
biomarker in studies of venous vessel contrast (1) and functional magnetic resonance 
imaging (2). In conventional susceptibility-based MRI methods, magnetic field perturbers 
produce intra-voxel spin dephasing which leads to decreased signal in magnitude images 
(3, 4). Quantitative susceptibility mapping (QSM), as documented in this thesis, is an 
extension of these conventional methods. It uses both the local frequency shift (LFS – 
calculated from the image phase) and the image magnitude information to reconstruct 
maps of intrinsic tissue magnetic susceptibility (5, 6). QS maps are more specific to tissue 
properties than conventional susceptibility-weighted imaging (SWI) because they remove 
the confounding influence of non-local fields and directly measure the mean magnetic 
field in each voxel. This field is proportional to the concentration of biological perturbers 
(7, 8).  
 Calculation of QS maps requires accurate processing of the image phase from 
multi-echo, multi-channel data. In particular, it requires a pipeline that accounts for (i) 
channel-dependent phase offsets (9, 10), (ii) phase wraps (11), (iii) non-local background 
field contributions (6) and (iv) the inverse field to source problem of calculating magnetic 
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susceptibility from LFS (5, 12). In this chapter, we outline the particular phase processing 
pipeline developed for QSM in this thesis. The pipeline also incorporates calculation of 
the apparent transverse relaxation rate (R2*).  
 
3.2 Phase and susceptibility map processing theory 
 The first step in generating QS maps from UHF MRI data is calculation of the 
unwrapped image phase from the complex k-space signal. However, for an MRI coil 
consisting of multiple elements, it is first necessary to perform element combination in a 
phase-sensitive manner. This may be accomplished using a number of different methods 
which differ in how they calculate coil sensitivities and whether or not they incorporate 
these sensitivities into the combination (10). To achieve acceptable acquisition times for 
whole brain imaging, channel combination generally must also be performed in 
conjunction with parallel imaging (13). In the sections which follow, the theory of the 
gradient echo signal received by a multi-element RF coil array is described and the 
optimal, phase sensitive coil combination techniques used in this thesis are highlighted. 
 For a T2*-weighted gradient echo image, the magnitude of the signal (Imag) decays 
exponentially as a function of the echo time (TE) and T2* (3, 4). The corresponding phase 
image, φ, is the sum of the global background phase offset, ϕb0, the phase term of the B1+ 
field, ϕb1+, and the local phase offset due to the susceptibility of tissue, ϕχ, where ϕχ is  
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expressed as:            
            [3.1] 
 The Δfχ term represents the resonance frequency shift of tissue compared to that of pure 
water. When multi-element RF coils are employed, each coil-element simultaneously 
receives signal from all voxels weighted by the coil-sensitivity profile (14). In this 
scenario, for the mth element in the coil array, the coil-sensitivity profile can be written as 
:                              [3.2]    
where Cmag,m and ϕm represent the element-specific magnitude and phase profiles of the 
mth element, respectively (15). The signal acquired by the mth coil-element, Sm,j, is the 
product of Cm and the true complex image (I)         
                                              [3.3] 
or   
              [3.4] 
where ϕb0 , ϕb1 , ϕm and ϕχ respectively represent the phase contributions from B0 
inhomogeneities, B1+ transmit fields, element-specific phase offsets and tissue structure.  
 Element-wise coil combination based on Eq. [3.4] can be performed with or 
without estimation of coil sensitivity profiles (16). In the following section, the most 
common coil combination techniques are introduced and the methods used for the 
experiments in this thesis are highlighted. 
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3.3 Element combination with coil sensitivity map estimation  
When coil sensitivity maps can be computed, combination generally proceeds using one 
of two techniques: (i) reference-based SENSE (ref-SENSE) (16) or (ii) self-calibrated 
SENSE (17). Reference-based SENSE requires two sets of images acquired with the 
same scan parameters. First an image is acquired with a standard volume coil. This is 
followed by a second image acquired using a multi-element coil. The sensitivity maps are 
then calculated by complex division of the individual coil element images by the image 
from the volume coil (16). Because the resulting sensitivity maps are affected by both 
noise and tissue contrast, they are usually smoothed before performing channel 
combination. The data from all coil elements is subsequently combined into a single 
image using least-squares optimization (14). 
 In self-calibrated SENSE, no volume coil image is necessary. The sensitivity 
profiles are derived from the complex data of each coil alone (17). The magnitude term of 
the coil sensitivity is obtained by using the root of sum of squares method (18). The 
phase term is then calculated either from the phase obtained from the complex sum of all 
coil-elements or by phase-matching (10). The combined complex image from all 
elements is then determined using least-squares optimization (17).  
 
3.4 Element combination without coil sensitivity map estimation  
At UHF, coil sensitivity profiles are generally not available because volume coils are not 
utilized for signal detection (10). The standard method for combining receivers when 
sensitivities are not available is to compute the square root of the sum of squares of the 
signal for each channel (16, 18). However, since this method discards the phase 
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information, it is unsuitable for QSM. In this case, phase sensitive coil combination can 
be performed using either (i) simple global phase alignment (10), (ii) phase correction 
relative to a reference coil (19), or (iii) by referencing the phase in a multi-echo sequence 
to that of the first echo (Hermitian inner product method) (10). An alternative procedure, 
specific to multi-echo data, is to perform a singular value decomposition (SVD) of the 
complex signal (19, 20). This yields the best estimate, in the least squares sense, of both 
magnetization and coil sensitivity. The two techniques employed for phase sensitive coil 
combination in this thesis, the Hermitian inner product method and multi-echo SVD are 
outlined below.  
 In the Hermitian inner product coil combination, the first echo complex image is 
subtracted from all subsequent echoes. This is followed by the complex sum of the 
images for all coil elements (10) as well as for all echoes (denoted by the variable ‘j’). In 
this manner, the ϕm and ϕb1+ phase contributions are removed because they are static 
(unchanging with echo time): 
        
                                [3.5] 
In Eq. [3.5], S*m,j is the complex conjugate of Sm,j and the sum is taken across channels. 
 In the multi-echo SVD coil combination, the individual coil element 
magnetization and sensitivity profiles are simultaneously obtained using a point-by-point 
SVD in the complex image domain. The SVD assumes coil elements have equal and 
uncorrelated noise. For each point in the image, the coil sensitivity, C, is represented by 
an N × 1 vector where N is the number of coil elements. The magnetization vector, G, is 
represented by a 1 × M vector, with M representing the number of echoes. 
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Consequently, the signal, S, can then be written as an N ×  M matrix: 
          S = CG         [3.6] 
In reality, the signal received from most multi-channel receive coils is unequal and 
uncorrelated. Consequently, S must be transformed using an estimate of the noise 
covariance matrix, V, such that S = V-1S. The SVD is then be computed as follows: 
         S-1 = UΣVH                    [3.7] 
where U and V are orthogonal matrices and Σ  represents a diagonal matrix of singular 
values (λ). The singular values in Σ  are organized such that the largest values occur at the 
top left corner of the matrix. The first right eigenvector of V gives an estimate of the 
magnetization. An estimate of the coil sensitivity matrix, C, is obtained from the first left 
eigenector of U. The final magnetization vector, G, which is the main parameter of 
interest, is obtained by scaling the first right eigenvector of V by λ1. 
      
3.5 Calculating frequency maps from the image phase  
 Once the complex signal from multiple receiver coils has been combined into one 
data set, the phase must be unwrapped to remove discontinuities. The wrapped phase 
contains values that range between –π and π and is not usable for QSM (3). Resolving the 
unwrapped phase involves adding or subtracting 2π from specific pixels located along the 
phase wrap boundaries (21). This may be performed temporally, if multi-echo data are 
available, or spatially if only a single-echo is acquired. In this thesis, the unwrapped 
phase was obtained using a combined spatial (21) and temporal domain unwrapping 
method (22, 23). The temporal unwrapping is initiated first and unwraps the phase errors 
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across multiple echo times by correcting for jumps larger than ± π occuring from one 
echo to the next (22). In areas of reduced phase SNR or where open-ended fringe lines 
exist, temporal unwrapping is insufficient. As a result, in our processing, temporal 
unwrapping is followed by a 3D spatial domain unwrapping which is a quality-guided, 
path-based method that uses the wrapped phase image SNR to guide the unwrapping path 
(21). By unwrapping the highest quality pixels first and the lowest quality pixels last, this 
method prevents error propagation in the unwrapping process (11). 
 To obtain frequency maps from the resulting unwrapped phase, the phase is 
temporally fit to the echo time utilizing a weighted linear regression (24). The linear 
regression is weighted by the variance in the phase data to reduce noise. This variance 
can be determined from the complex data, according to (25): 
                   [3.8] 
 
where ρ and φ are the magnitude and phase of the voxel and σ2 denotes the variance 
operator. Equation [3.8] assumes the distribution of noise in the complex MRI data is  
zero-mean, Gaussian. The specific formula used for the weighted linear regression is as 
follows:                           [3.9] 
 
where ftot denotes the desired macroscopic frequency map and ρi and φi are the magnitude 
and phase of the voxel at time ti (24). However, equation [3.9] does not hold for the case 
of single-echo, gradient echo acquisitions. In the case of single-echo acquisitions, the  
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macroscopic frequency shift is obtained from the following equation:
 
           [3.10]
 
 
where the second multiplicative term on the right side of the equation [3.10] denotes the 
variance weighting (3). 
  
3.6 Background field removal         
 Once the macroscopic frequency maps have been reconstructed, it is necessary to 
remove the influence of frequency contributions arising from air-tissue interfaces, high-
order shimming, and other sources of field perturbation existing outside the brain (5). To 
remove these background contributions, the macroscopic frequency variation is divided 
into frequency contributions originating from sources outside the brain (fext) and those 
originating from sources inside the brain (fint) according to the Sophisticated Harmonic 
Artifact Reduction from Phase data (SHARP) method first proposed by Schweser et al. 
(6).  Accordingly, the total frequency shift at a voxel (ftot) is given by: 
               ftot = fint  +  fext           [3.11] 
Determination of fint  from ftot is performed using the known physical properties of the 
internal and external frequency shifts. fext satisfies Laplace’s equation because it results 
from sources existing outside the volume of interest (VOI):              
                 [3.12] 
Consequently, applying the Laplacian operator to ftot results in the following relationship: 
           [3.13] 
The solution to Eq. [3.13] is calculated by applying the mean value property of harmonic 
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functions (26, 27). According to this property, any harmonic function is preserved under 
convolution with a non-negative, radially symmetric, normalized function (26). As it 
applies to background field removal, a radially symmetric, normalized function h(r) can 
be multiplied into equation [3.11] and subtracted from the original total frequency shift, 
resulting in the following interim data set:              
                finterim = ftot – h(r) ⊗ ftot      [3.14] 
One example of the convolution function is a radially symmetric spherical kernel. An 
example of such a kernel for radii varying from 7 – 11 mm is illustrated below: 
 
Figure 3.1: SHARP background filter convolution kernels with varying radii. A - C 
show spherical kernels with radii of 7, 9 and 11 mm respectively. 
 
In our specific implementation of Eq. [3.14], the convolution function, h(r), was a 
spherical kernel which extended over a radius of  7 – 11 mm. A larger spherical 
convolution kernel resulted in improved background field removal at the expense of 
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 increased erosion of pixels at the edge of the brain:  
 
Figure 3.2: SHARP filtered LFS maps generated using an increasing spherical kernel 
radius. A - C show LFS maps generated with SHARP spherical kernels of 7, 9 and 11 
mm respectively. In C, background field removal is more efficient at the center of the 
brain, while more regions at the edge of the brain are lost due to erosion.  
 
Since fext  obeys the harmonic mean value theorem, Eq. [3.14] can be reduced to: 
        finterim = fint – h(r) ⊗ fint 
                 = (σ - h(r))⊗ fint        [3.15] 
where σ represents the Dirac delta function. As a result, Eq. [3.15] can be solved to 
isolate  fint  using a deconvolution operation: 
           fint =(σ - h(r)) ⊗-1 finterim        [3.16] 
The values in finterim are corrupted at the edge of the VOI because the convolution is 
carried out using a kernel which extends into the region outside the brain. In order to 
compensate for this effect, the deconvolution of Eq. [3.16] must be limited to a region 
where non-zero values of finterim  exist. This results in an erosion of the phase data at the 
edge of the brain by an amount equal to the radius of the convolution kernel function. 
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3.7 Calculating volume magnetic susceptibility from the LFS map 
According to Maxwell’s equations, the true susceptibility distribution in a tissue is related  
to the internal frequency shift by the following convolution: 
                    [3.17] 
where ∆B(r) denotes the magnetic field shift and θrr’ is the angle produced by the 
projection of the long axis of the susceptibility inclusion onto the external magnetic field 
(28). The solution to this convolution integral over a volume is obtained in the spatial 
domain by using a Green’s function expansion for simple geometries. However, in 
medical imaging both ∆B(r) and χ(r’) are defined by large matrices. For practical 
computation, the inversion of Eq. [3.17] in the spatial domain requires tens to hundreds 
of gigabytes, if each matrix is formed explicitly (5). The computation of  χ(r’) from Eq. 
[3.17] can be performed more simply if the problem is formulated in the Fourier domain 
(29). With this approach, the magnetic susceptibility map can be numerically calculated 
from the the LFS utilizing a k-space based, regularized inversion with a conjugate 
gradient algorithm. By defining the k-space representation of fL as fL(k) and the k-space 
representation of Δχ as Δχ(k), the local resonance frequency map is related to the volume 
magnetic susceptibility as follows (5): 
                          [3.18]     
 Equation [3.18] can also be written in matrix form as: 
                                                       [3.19] 
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where δ denotes the k-space local frequency shift, C represents the Fourier domain dipole 
convolution kernel and the variable X denotes the Fourier domain susceptibility  
distribution of interest. A visual representation of the convolution function, C, in the axial 
plane is given below: 
 
Figure 3.3: Numerically-generated dipole convolution kernel employed in QSM 
inversion. The kernel is displayed using: (A) a 2D view in the kz-kx (sagittal plane) and 
(B) a 2D view in the kx-ky plane (axial plane). The black lines in Fig. 3.3B denote regions 
of the Fourier domain where the convolution kernel has very small values. This property 
of the convolution kernel makes the inversion of equation [3.18] an ill-conditioned 
problem.  
 
Calculation of QS maps from the LFS requires inversion of the linear system of equations 
represented by Eq. [3.19]. Theoretically, direct inversion can be used to yield X. 
However, since the dipole convolution function, C, has zeros on a conical surface defined 
by 2kz2 = kx2 + ky2 (this is visually displayed by the black lines in Fig. 3.3B), a direct 
inversion is ill-conditioned in areas where C is small. A common method used for 
reconstruction of accurate susceptibility maps is quadratic minimization of a regularized 
least-squares objective function (5, 6). For this purpose, Eq. [3.19] can be written as a  
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weighted least-squares problem with spatial priors: 
                                                 [3.20] 
 
where W, W0 and W1 are weighting matrices (spatial prior information) defined as: a 
binary mask of the brain in the second echo magnitude image (W0), the magnitude image 
itself (W) and the gradient norm of the magnitude image (W1). These spatial priors for a 
gradient echo brain image obtained from 7 T MRI  are displayed below: 
 
Figure 3.4: Spatial priors used in calculation of susceptibility maps from LFS maps. 
 
A minimum quadratic form of Eq. [3.20] is solved using the conjugate gradient normal 
residual (CGNR) method in the numerical implementation of QSM (5): 
                   [3.21] 
 
Previous work in our lab has revealed that optimum values of α2 and β2 = 1 × 104  are 
appropriate for realistic reconstruction of susceptibility in human brain at 7 T. These 
values were chosen because they resulted in the smallest log residual at the transition 
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point in the L-curve. They also reconstructed constant, realistic values for susceptibility 
over a range of iterative steps in the CGNR algorithm implemented in Matlab (R2013). 
 Accurate, reproducible QS mapping requires calculation of QS values relative to a 
common reference structure. In this study, the mean QS value calculated from bilateral 
ROIs in frontal deep white matter was used as a reference tissue. Frontal white matter has 
previously (12) been used effectively as a reference structure in high-resolution QS 
mapping at 7 T in healthy subjects.  
 
Figure 3.5: Full processing pipeline utilized in this thesis for channel combination, R2*, 
LFS and QS mapping. 
 
3.8 R2* mapping 
Exponential fitting of the MRI signal decay has been used extensively in MR research to 
perform quantitative T2* and T2 mapping (30, 31). For example, nuclear-nuclear and 
nuclear-electron magnetic interactions give rise to the longitudinal (T1) and transverse 
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(T2) relaxation rates of water molecules used to characterize tissue properties in 
quantitative MRI (32). Another relaxation-based quantitative MRI parameter often 
employed to characterize tissue properties is the apparent transverse relaxation rate,       
R2* = 1/T2* (3, 16). The variable R2* = R2  + R2′, with R2′ representing the contribution to 
the signal relaxation rate from local magnetic field inhomogeneities. R2′ is mediated by 
two major factors: (i) the difference in local magnetic field experienced by nuclei in 
different magnetic environments and (ii) nuclear spin diffusion through an 
inhomogeneous magnetic field (33). 
 If the MRI signal decay due to magnetic moment dephasing is faster than the rate 
of diffusion, the signal decay due to R2* is said to be in the "static dephasing regime" or 
"slow molecular motion regime" (33). In this case, the dominant contribution to R2* is the 
difference in local magnetic fields experienced by nuclei and the influence of diffusion 
may be neglected. In this thesis, the static dephasing regime is assumed when computing 
all the susceptibility-based qMRI metrics. 
 The signal properties of water protons relaxing under the influence of R2* = 1/T2*  
decay can be modeled for a gradient echo acquisition using the following expression: 
! ! ! ! !!!!!!!!! ! ! ! !! !![3.22] 
 
where TE represents the time between the RF excitation and the center of the data 
acquisition and S0 identifies the magnitude signal intensity prior to any T2* decay (3). T2* 
can be calculated based on equation [3.22] by measuring the decay in a gradient echo 
acquisition at various time points after the RF excitation pulse. These measurements can 
then be fit assuming a mono-exponential decay curve (red line in figure 2.10 of Chapter 
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2). Acquisition of the decay curve at various time points is performed using either a 2D 
or 3D MRI sequence. Because of its higher SNR and shorter scan time for whole-brain 
imaging, 3D gradient echo imaging was employed in all work documented in this thesis.  
 Quantitative maps of the apparent transverse relaxation rate, R2*, were calculated 
using an interior-point, least-squares fitting routine for non-linear equations. For the data 
acquired in the MS imaging study, the following mono-exponential decay function: 
                   
  
S(TE) = S0 ⋅exp(
TE
T2*
) ⋅ sinc(γ ⋅ ΔBz ⋅TE2 )         [3.23]   
was fit to the magnitude data to account for the effects of B0 field inhomogeneity in the 
R2* decay signal (34, 35). In equation [3.23], TE represents the echo time and S0 
represents the signal intensity at TE = 0 ms. ∆Bz represents the gradient of the magnetic 
field along the Z-direction. The ∆Bz term must be calculated independently for use in     
Eq. [3.23]. The sinc term in Eq. [3.23] is applied to model the effect of B0 field 
inhomogeneity on the T2*  decay curve (34).  
 The next chapter presents a fundamental research study using combined R2*, LFS 
and QS mapping with multi-echo, gradient echo MRI at high-field and ultra-high 
resolution.  
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Chapter 4  
Origins of R2* Orientation Dependence in Gray and White Matter 
Our brain – with its 100 billion neurons and quadrillion synapses, give or take a few 
billion here or there – is one of the most complex entities to demystify.  
– Eric J. Tople, The Creative Destruction of Medicine 
 
4.1 Introduction 
In many neurological diseases such as multiple sclerosis, Alzheimer’s and Parkinson’s, 
and in conditions following traumatic brain injury, microstructural changes occur in gray 
and white matter (1-4). One method for quantifying these microstructural changes is 
mapping of the effective transverse relaxation rate (R2*). Along with T1 and T2, T2*        
(1/ R2*) has been viewed as a fundamental MRI tissue parameter, affected by several 
factors including myelin content (5, 6), endogenous ferritin-based (Fe3+) iron (7, 8), tissue 
microstructure (6) and paramagnetic, blood deoxyhemoglobin (9). However, a number of 
recent studies have reported a somewhat surprising dependence of R2* on tissue 
orientation, at least in white matter (10-12). The purpose of this paper was to investigate 
the mechanisms that could contribute to this orientation dependence of R2* in both gray 
and white matter. Because R2* is influenced by magnetic field perturbations, we 
examined the role of the local Larmor frequency shift (fL) and the quantitative magnetic 
susceptibility (Δχ), parameters that relate field and frequency. Through this analysis we 
identified novel scaling relations that relate R2′ to the local Larmor frequency shift 
calculated after removal of macroscopic field inhomogeneities. Additionally, we 
compared for the first time,  two methods for computing Δχ in gray and white matter: (i) 
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fitting the Generalized Lorentzian (GL) Model of field perturbers (13) to fL measured at 
multiple brain orientations and (ii) magnitude-regularized dipole inversion (14). The 
difference between these two estimates represents the local frequency shift due to a 
cylindrical, axon geometry and is a marker of axonal integrity. 
 Having modeled the orientation dependence, we next examined the effect of 
myelin and iron on both R2* and Δχ. We demonstrated a linear correlation between these 
quantities and optical density (OD) derived from DAB-enhanced Perls stain (sensitive to 
ferritin-based iron) for cortical gray matter. Similarly, using OD derived from 
solochrome cyanine-R stained slides in rat brain major white matter fiber regions, we 
showed strong positive correlations between the transverse relaxation constants, R2 and 
R2′, and myelin density. Taken together, our results demonstrate that observed R2* values 
in ex vivo brains can be explained by a sinusoidal dependence on tissue microstructure 
orientation in conjunction with a linear dependence on the myelin concentration in 
cortical gray and white matter. In deeper gray matter structures with no preferred 
symmetry axis, R2* does not have an orientation dependence but retains a linear 
dependence on iron concentration.                                
     
4.2 Theory 
4.2.1 Orientation dependence of R2* white matter 
Recently, Lee et al. (12) used a theoretical model developed by Yablonskiy and Haacke 
(15) to fit an orientation-dependence curve to R2* data from ex vivo, fixed human corpus 
callosum at 7 T. The model assumes that the orientation dependence of R2*  in groups of 
close-packed, parallel white matter fibers can be approximated with the following 
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equation:  
 
                                     [4.1]                   
 
where C0, C1 and ψ0 are constants and θ is the angle of the longitudinal axis of the fiber 
tract relative to the B0 field. Eq. 4.1 is an extension of the standard relationship for R2* : 
 
                         [4.2] 
                   
The C0 constant in Eq. 4.1 represents the conventional transverse relaxation rate, R2, as 
well as any contributions to R2′ that are not angularly dependent (e.g. R2′ shifts due to 
endogenous ferritin-based iron). For white matter fiber bundles, the constant C1 is defined 
as 
                       [4.3] 
 
where the variable ζ represents the volume fraction of field perturbers and Δχ represents 
the magnetic susceptibility difference between a fiber bundle and the medium 
surrounding the bundle. In this paper, we validated the orientation dependence model of 
Eq. 4.1 (specifically, the relation C1 = 2π ω0  ζ Δχ ) by comparing the fitted parameters 
from the linear R2* model to the value of Δχ calculated from the Generalized Lorentzian 
model of field perturbers (further discussed in the next section of this paper). To perform 
this comparison, the OD of myelin obtained from histochemical staining and slide 
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registration was used as a surrogate for the volume fraction (ζ). Throughout this paper we 
define the R2′ value as being the same as C1. According to the original derivation (15), 
the true value of R2′ for a network of parallel fibers is 2π ω0 ζ Δχ sin(2θ). Since we are 
explicitly modeling the orientation dependence of R2′, we use the constant C1 to define 
the amplitude of the R2′ variation with fiber angle. Consequently, we treat C1 as a 
surrogate measure of R2′. 
The orientation-dependence of the R2* signal has also been characterized with an 
alternative, second-order model of field-perturbers. This model postulates that two 
distinct components contribute to the orientation dependence of R2* in white matter: (i) 
an isotropic component associated with the cylindrical geometry of myelinated axons 
(13) and (ii) an anisotropic component associated with the phospholipid bilayer structure 
of myelin (12). The equation for the second-order model is  
 
              [4.4] 
 
In this study, we compared the linear and second-order R2* models in rat brain major 
white matter fiber bundles.  
4.2.2 Gray matter 
Eq. 4.1 was also used to fit R2* orientation dependence in gray matter. The orientation of 
gray matter was defined as the angle between the normal to the cortical surface and B0. 
This technique, previously employed by Cohen-Adad (16), is physically motivated by the 
fact that myelinated white matter tracts project into cortical gray matter where they 
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synapse onto cortical neurons, conferring a preferred axis of symmetry in the cortical 
gray matter.   
4.2.3 Orientation-dependence of fL in white matter 
The theoretical field shift around a susceptibility inclusion has conventionally been 
calculated in NMR using the Lorentzian sphere formalism. However, this approach has 
been questioned for modeling brain tissue structures such as axons that have non-
spherical boundaries. Instead, an alternative Generalized Lorentzian Model (GL model) 
has been suggested by He and Yablonskiy (13) for modeling field perturbers in the static 
dephasing regime. This model, with application to external capsule white matter in rat 
brain, is discussed in detail in what follows.  
 The external capsule is a large white matter tract that extends longitudinally 
through the rat brain in the anterior-posterior direction. The local Larmor frequency shift 
of water molecules moving inside parallel axons of the external capsule bundle relative to 
the external gray matter can be calculated using the Lorentzian cylinder approximation of 
He and Yablonskiy (13). In this approximation, a model Lorentzian cylinder surrounds 
the white matter bundle and has a diameter larger than that of the bundle. The nuclei of 
water molecules inside the axon bundle experience a frequency shift that is the 
summation of the contributions from point magnetic dipoles which exist either (i) inside 
or (ii) outside a Lorentzian cylinder. The magnetic field experienced by nuclei due to 
dipoles existing inside the Lorentzian cylinder averages to zero because the average 
magnetic field around a point dipole is zero. Consequently, the frequency shifts of the 
nuclei inside the external capsule are influenced by point dipoles in the medium outside 
the cylinder of Lorentz.  
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 Along the anterior-posterior direction, the external capsule bundle can be 
considered as an infinite circular cylinder with a length significantly larger than its 
diameter. In this regime, we can write the frequency shift for external capsule white 
matter as: 
                                                            [4.5]
                                                   
     
                                          
where fL,WM  is the local frequency shift in the white matter relative to the surrounding, 
isotropic gray matter medium, χae (ppm) is the magnetic susceptibility of the isotropic 
medium surrounding the axon bundle, χWM = 0.067 ppm is the magnetic susceptibility of 
myelin in white matter (13) and θ is the orientation angle of an axon bundle relative to the 
B0 field.  
 Throughout this chapter, Δχ, calculated by fitting the GL model (Eq. 4.5) to fL 
measured with varying brain orientations, is denoted as ΔχGLModel  to differentiate it from 
the magnetic susceptibility calculated using a regularized dipole inversion method 
(Δχdipole) outlined below. All magnetic susceptibility values are written in SI units and are 
calculated relative to the average magnetic susceptibility in an adjacent cortical gray 
matter ROI.  
4.2.4 Gray Matter 
We also examined the orientation dependence of  fL in cortical gray matter. The presence 
of cortical fibers should, theoretically, give rise to an orientation dependence described 
by Eq. 4.5. We tested this hypothesis in cortical gray matter regions evenly distributed 
around the cortex. The Δχ = χae - χWM term in Eq. 4.5 was replaced by Δχ = χae - χGM_average   
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where χGM_average  is the average susceptibility of gray matter measured from multiple ROIs 
evenly distributed around the cortex.  
4.2.5 Reconstruction of quantitative susceptibility maps from single-orientation fL maps 
According to Maxwell’s equations, a volume magnetic susceptibility distribution, Δχ 
(ppb), produces an associated local frequency shift, fL (Hz). Defining the k-space 
representation of fL as fL(k) and the k-space representation of Δχ as Δχ(k), the local 
resonance frequency map is related to the volume magnetic susceptibility as follows (14, 
17, 18): 
                                
       
[4.6] 
Calculation of Δχdipole maps from the fL requires inversion of Eq. 4.6. A common method 
used for this inversion is quadratic minimization of a regularized, least-squares objective 
function (14). The technique from (14) was employed for calculation of Δχdipole in this 
work by implementing a regularized CGNR algorithm in Matlab (R2008b, The 
MathWorks, Natwick, MA, USA). Calculation of magnetic susceptibility in this study 
was performed using a single-orientation. 
 
4.3 Materials and Methods  
4.3.1 Measuring the orientation dependence of R2* and
 fL 
The orientation dependence of R2* and  fL was experimentally measured in both 
hemispheres of the rat brain, in white matter fiber tracts and gray matter (n=3 brains, 2 
hemispheres, 18 orientations). Each rat brain was scanned with the medial fissure of the 
brain oriented at 18 different sampling angles relative to the main field of the magnet. 
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Specifically, each brain was rotated to (i) eight unique angles of n × 45° (n = 1…8) about 
the y-axis shown in Fig. 4.1c, as well as (ii) 10 additional angles chosen to produce an 
even sampling of the unit sphere. Reproducible rotations were achieved by using the 
sample holder shown in Fig. 4.1.  
 
 
Figure 4.1: Custom-machined sample container/experimental setup for imaging. (a) 
Custom-machined sample container and (b,c) experimental setup illustrating rat brain 
immersed in MRI invisible, fluorinated fluid. Each increment on the sample container 
represents a ten degree rotation about the y-axis. 
 
 To improve SNR, five contiguous, 100 µm slices in each R2* and fL map were 
averaged. An average R2* and  fL was measured in each ROI specified in Fig. 4.2a (white 
matter) and 2e,i (gray matter). The orientation of cortical fibers in each gray matter ROI 
was determined by referencing to a penetrating cortical vein adjacent to, but not included 
in, the ROI. These veins conveniently define the normal to the cortical surface.  
 Data from multiple ROIs in each sample are displayed together in Fig. 4.2(b-l). 
The minimum point of each sinusoidal, orientation-dependence curve from each ROI was 
phase shifted so that the vector that defined the initial orientation was effectively aligned 
with the B0 field. Once the sinusoidal curves were aligned, R2* and fL data for each ROI 
was averaged for the three animals. 
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4.3.2 Preparation of rat brain tissue samples 
Three adult, male Sprague-Dawley rats (n=3; 250-300 g) were purchased from Charles 
River Laboratories (Sherbrooke, Quebec, Canada). Rat brains were excised and fixed in 
4% formalin solution for two weeks prior to imaging. Fixation preserves biological 
tissues from decay by preventing autolysis and halting chemical reactions. It also 
increases mechanical strength of tissue in preparation for chemical staining. All animal 
protocols were undertaken in accordance with Animal Care Guidelines, with approval 
from the Animal Use Subcommittee of Western University.   
 For imaging, the brains were placed inside a 2.5 cm diameter plastic sphere filled 
with an MR-invisible, fluorinated solution (Lubrication Technology, Inc., 
Franklin Furnace, OH). A custom-machined, spherical sample holder allowed accurate 
rotation of the brain in order to image the sample at different angles relative to the field 
(Fig. 4.1a-c), while the fluorinated solution minimized the formation of susceptibility-
based edge effects in and around the brain because it has a susceptibility which is similar 
to that of cortical grey matter. 
4.3.3 MRI protocol 
Imaging was performed on a 9.4 T, 31 cm horizontal bore animal MRI scanner (Agilent 
Technologies, Santa Clara, California). An in-house designed B0 field mapping sequence, 
RASTAMAP (19), was utilized to perform automated higher-order shimming before 
imaging.  The RF coil used for all data collection was a 4 cm diameter millipede coil 
(Agilent Technologies, Santa Clara, California).  
A 3D multi-echo gradient echo acquisition with an imaging field of view of 25.6 × 
25.6 × 25.6 mm3 and an isotropic resolution of 100 µm was used for imaging all brain 
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orientations. The scan parameters were:  TR = 50 ms, TE1 = 3.84 ms, echo spacing = 5.56 
ms and 6 echoes.  
 
4.3.4 MR image post-processing and data analysis 
From the multi-echo gradient echo magnitude data, mono-exponential R2* maps were 
generated using a Levenberg-Marquardt weighted least squares fitting routine. The 
variance in the magnitude images was employed as a weighting term in the least-squares 
fitting.  
 To correct for the influence of B0 field inhomogeneity, the voxel spread function 
(VSF) approach was used as described in (20). The VSF method accounts for the 
combined effects of both through-plane and in-plane field inhomogeneities, as well as 
signal leakage from neighbouring voxels. 
 For registration of the data acquired with different brain orientations, the 
magnitude image corresponding to the second echo at each brain orientation was co-
registered to the volume acquired with the medial fissure of the brain aligned at 0° 
relative to the B0 field. This was performed utilizing the FSL FLIRT tool for rigid body 
affine transformations (21).  
For phase processing, raw phase images were unwrapped in three-dimensions using 
a region-growing algorithm (22). A Fourier filtering process was then applied to remove 
background fields. First, a 3D, Gaussian, low-pass filter was applied to the Fourier 
transform of the unwrapped phase data (23). The Gaussian filter had the following  
functional form: 
                                                [4.7] 
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The value of σ for the convolution kernel was set to 0.007 m-1. This value was chosen to 
sufficiently remove background field contributions, while still preserving local frequency 
contrast between gray and white matter. A 3D inverse Fourier transform was then applied 
to the result of the Fourier domain multiplication to generate low-pass filtered, spatial 
domain data. Subtraction of this low pass filtered data from the original, unwrapped 
phase data produced a high pass filtered phase image.  
 After background filtering, the phase maps were fit using a weighted linear 
regression to yield the off-resonance frequency at each voxel, i.e. fL (24). The linear 
regression was weighted by the phase noise variances.  
4.3.5 Histological staining 
For histological staining, brains were prepared for sectioning using a Leica RM2255 
Microtome (Cryostat Microsystems, Wetzlar, Germany) in accordance with previously 
published methods (25). Sections were cut at a thickness of 5 µm and de-paraffinized 
before staining by heating at 50 °C. Every second slice was then stained with solochrome 
cyanine R (ScR) for myelin detection (25). The remaining slices were stained for iron 
using diaminobenzidine (DAB)-enhanced Perls stain (26).  
The microscopy slides were digitized using a Zeiss Axio Optical Imager (Carl Zeiss 
AG, Jena, Germany) at 40× magnification. The digital images were then co-registered to 
the R2* maps using the FSL FLIRT registration tool (21). Subsequently, a value for 
optical density, OD = -log10(I/Io), was computed at each pixel, where I represents the 
image intensity for light passing through tissue and Io represents the image intensity for 
light passing through a region of the slide where only the background level of staining 
was observed. 
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4.4 Results and Discussion          
4.4.1 Imaging setup 
Each of three rat brain samples was imaged using a multi-echo, gradient echo sequence 
with the medial fissure of the brain oriented at 18 different sampling angles relative to the 
main field of the magnet. Specifically, the brains were rotated to (i) eight unique angles 
of n × 45° (n = 1…8) about the y-axis shown in Fig. 4.1c, as well as (ii) 10 additional 
angles chosen to produce an even sampling of the unit sphere. Reproducible rotations 
were achieved by using the sample holder shown in Fig. 4.1.  
4.4.2 Orientation dependence of R2* in white matter 
Fig. 4.2b illustrates the change in R2* as a function of the orientation of the four ROIs in 
the external capsule. Statistically significant changes in the white matter R2* for different 
brain orientations were observed at the confidence level of p < 0.01. This significance 
level was computed using a balanced one-way ANOVA for comparing independent 
samples containing mutually independent observations. The orientation-dependence of 
R2* was well fit by a sin(2θ  + ψ0) relationship, with an average peak-to-peak variation of 
ΔR2* = 3.11 ± 0.62 s-1 (averaged across all external capsule ROIs in both hemispheres). 
 The linear and second-order R2* models of Eq. 4.1 and 4.4 were both fit to the R2* 
data in white matter. From fitting of the linear model, three parameters, C1, C0 and ψ0, 
related to tissue composition (12) were then calculated. The full set of derived parameters 
for all rat brains are listed in Table 4.1. To generate those values, the linear model was fit 
to the data in each ROI of Fig. 4.2a for each brain sample. The fitted values for external 
capsule ROIs in the same hemisphere for the same sample were then averaged. A C0  
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Figure 4.2: R2* and fL changes observed in gray and white matter as a function of 
fiber orientation relative to B0 (for white matter) and surface normal orientation 
relative to B0 (for gray matter). The regions of interest (ROIs) used for this analysis are 
displayed in Fig. 4.2 a, e and i. The ROIs used for analysis are overlaid on the second 
echo magnitude image with the medial fissure of the brain oriented parallel to B0. The 
linear R2* model is overlaid on Fig. 4.2b and f. The GL model fit is overlaid on Fig. 4.2c 
and g. Fig. 4.2j and k demonstrate the R2* and fL changes observed in the basal ganglia 
structures (lateral habenular nuclei) as a function of brain orientation. Fig. 4.2d, h and l 
demonstrate the linear relationships between the orientation dependence of R2* and  fL in 
white and gray matter. 
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Table 4.1: Parameters derived from fitting the linear R2* model in external capsule 
white matter. Data is shown for each of the three brain samples (e.g. S1 = brain sample 
1). Pearson correlation coefficients (r) are given in the right-most column of the table. 
 
ROI Location C0 (s-1) C1 (s-1) ψ0 (°) r 
Left Brain, S1 59.89 ± 0.27 2.47 ± 0.37 11.74 ± 9.28 0.849 
Right Brain, S1 59.36 ± 0.16 1.05 ± 0.23 32.58 ± 11.93 0.750 
Left Brain, S2 64.23 ± 0.11 1.53 ± 0.11 22.84 ± 5.23 0.926 
Right Brain, S2 64.71 ± 0.23 1.83 ± 0.32 21.73 ± 10.36 0.833 
Left Brain, S3 62.14 ± 0.26 1.23 ± 0.39 15.23 ± 16.82 0.633 
Right Brain, S3 62.47 ± 0.24 1.21 ± 0.32 21.39 ± 16.53 0.702 
 
value of 62.13 ± 0.54 s–1 was observed when all external capsule white matter ROIs were 
averaged (n=3). A two-tailed Welch’s t-test revealed no statistically significant difference 
(p < 0.05) between C0 computed in the left and right brain external capsule. 
 The second-order model (Eq. 4.4) was also fit to the R2* orientation data in 
external capsule white matter. The derived parameters are listed in Table 4.2. The 
correlation coefficients in Table 4.2 demonstrate that the second-order model did not 
provide significantly improved fitting. For this reason, no further analysis was conducted 
with this higher-order model. Application of the higher-order model is difficult due to the 
confounding contributions of residual background fields (which may also have a sin(4θ) 
dependence). In previous studies, SNR considerations revealed that large ROIs are 
necessary for observing the sin(4θ) component. Such large ROIs are prone to introducing 
error in the measured R2* orientation dependence because the mean value of R2*  
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Table 4.2: Parameters derived from fitting the higher-order R2* model in external 
capsule white matter. Data is shown for each of the three brain samples (e.g. S1 = brain 
sample 1). Pearson correlation coefficients (r) are given in the right-most column of the 
table. 
 
ROI Location C0 (s-1) C1 (s-1) C2 (s-1) ψ0 (°) r 
Left Brain, S1 59.90 ± 0.23 2.70 ± 0.33 0.88 ± 0.32 11.92 ± 5.08 0.825 
Right Brain, S1 59.44 ± 0.16 1.52 ± 0.34 1.32 ± 0.52 6.56 ± 3.09 0.814 
Left Brain, S2 64.45 ± 0.11 1.42 ± 0.17 -0.35 ± 0.14 13.10 ± 5.45 0.642 
Right Brain, S2 64.69 ± 0.23 1.82 ± 0.31 -0.55 ± 0.45 22.64 ± 8.30 0.739 
Left Brain, S3 63.02 ± 0.25 1.20 ± 0.38 0.51 ± 0.33 19.84 ± 14.32 0.885 
Right Brain, S3 62.47 ± 0.24 1.18 ± 0.33 0.50 ± 0.44 11.50 ± 13.03 0.742 
 
 
calculated from a large ROI is more sensitive to background fields. Such fields may vary 
over the length scale of the ROIs (12). Moreover, ROI-based analysis precludes voxel-
wise interpretation of the anisotropic component, which is the ultimate goal of fitting the 
proposed second-order model. 
4.4.3 Gray matter 
Fig. 4.2f displays the changes in R2* of cortical gray matter as the brain was rotated. Gray 
matter R2* varied sinusoidally with surface normal orientation and was well fit by the 
linear model. The average trough-to-peak R2* variation in the cortex was ΔR2* = 0.94 ± 
0.32 s-1 (averaged across all gray matter ROIs in both hemispheres). The parameters 
derived from fitting the linear model in gray matter are listed in Table 4.3. 
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Table 4.3: Results of the linear model fit to R2
* in gray matter. Data is shown for each 
of the three brain samples (e.g. S1 = brain sample 1). Pearson correlation coefficients (r) 
are given in the right-most column of the table.  
 
ROI Location C0 (s-1) C1 (s-1) ψ0 (°) r 
Left Brain, S1 46.36 ± 0.16 0.41 ± 0.16 18.02 ± 7.89 0.718 
Right Brain, S1 45.10 ± 0.08 0.56 ± 0.07 20.50 ± 4.09 0.810 
Left Brain, S2 46.88 ± 0.18 0.62 ± 0.15 13.52 ± 10.06 0.659 
Right Brain, S2 47.11 ± 0.22 0.45 ± 0.27 24.19 ± 23.98 0.514 
Left Brain, S3 46.68 ± 0.11 0.34 ± 0.10 31.85 ± 9.07 0.745 
Right Brain, S3 46.57 ± 0.12 0.41 ± 0.09 43.16 ± 6.27 0.796 
 
The parameter C1 was used to estimate the trough-to-peak change in R2*  R2
* of sub-
cortical gray matter did not display significant changes with brain orientation (Fig. 4.2i 
and j). The ROIs for this analysis were chosen in the sub-cortical, lateral-habenular 
nucleus. The notable difference between Fig. 4.2f (cortical gray matter) and j (deep gray 
matter) supports the premise that the orientation of penetrating cortical white matter 
fibers affects estimates of mono-exponential R2* in gray matter. Further, it identifies that 
changes in R2* with brain orientation in the largely isotropic structures (e.g. glial cells and 
astrocytes) of the basal ganglia are insignificant. It is not possible to completely exclude 
the contribution of coherently oriented microvasculature structures from the orientation-
dependent R2* in cortical gray matter. Further work is necessary to more completely 
evaluate the quantitative contribution of cortical microvasculature to the orientation-
dependent R2* signal. 
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4.4.4 Orientation-dependence of fL in white matter 
The relationship between fL and white matter fiber orientation is illustrated in Fig. 4.2c. 
The mean trough-to-peak amplitude of the fL shift was 7.2 ± 3.8 Hz. Fibers oriented 
perpendicular to the B0 field had a positive frequency shift compared to those oriented 
parallel to the field. This trend is characteristic of any substance that is less diamagnetic 
than water. For instance, when myelin becomes less diamagnetic than water due to the 
fixation process (27, 28), this trend is observed. The results are consistent with previously 
observed effects of fixation on the magnetic susceptibility of myelin. The average 
ΔχGLModel measured in external capsule white matter was 24.9 ± 2.25 ppb. This compares 
very well to previous values of 26 ppb in mouse white matter (6).  
Fig. 4.2d identifies a linear relationship between the orientation dependencies of 
R2* and fL in the oriented white matter fibers of the external capsule. The specific linear 
relation is given by R2* = 0.23·fL + 65.28. The influence of R2 is represented by the 
vertical offset term (65.28 s-1), while a scaling constant which relates R2′ to fL is given by 
the slope of the line (0.23). R2′ is influenced by the local frequency shift in a voxel for 
each tissue geometry and tissue composition (15). Breaking down the respective 
contributions of R2 and R2′ in this manner may be useful in identifying subtle changes 
occurring in gray and white matter in the course of disease development. For instance, the 
early stages of demyelination which occur prior to removal of myelin debris in multiple 
sclerosis may preferentially effect R2′, while leaving R2  unchanged. 
4.4.5 Gray Matter 
The relationship between cortical gray matter fL and cortical fiber orientation is illustrated 
in Fig. 4.2g. The data was well fit by the GL model of Eq. 4.3 The average amplitude of 
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gray matter fL variation was 0.56 ± 0.13 Hz. Table 4.4 (right-most columns) shows the 
values of Δχ calculated from the GL model fit. The average ΔχGLModel  measured in gray 
matter was 4.5 ± 1.39 ppb. Since this represents the first attempt to measure susceptibility 
of gray matter using the GL model, there are no literature values with which to compare 
this measurement . However, the ΔχGLModel can be compared to Δχdipole , as performed in 
the section which follows. The ROIs used for this analysis of fL orientation-dependence in 
cortical gray matter were chosen with reference to an adjacent intracortical vein but not 
including this vein. The ROIs were specifically selected using fL maps to avoid including 
local fields from large intracortical veins which can modulate fL (29).  
 
Table 4.4: Parameters calculated from the GL model fit of fL  vs. cortical surface 
normal orientation (for gray matter) and fL  vs. principal fiber orientation (for white 
matter). The susceptibility values are referenced to the average susceptibility of 
surrounding gray matter. Data is shown for each of the three brain samples (e.g. S1 = 
brain sample 1). Pearson correlation coefficients (r) are given in the right-most column of 
the table. 
 
 Gray Matter White Matter 
ROI Location Δχ  (ppb) r Δχ  (ppb) r 
Left Brain, S1 2.55 ± 1.60 0.871 25.13 ± 3.77 0.780 
Right Brain, S1 4.04 ± 1.96 0.734 20.11 ± 2.64 0.759 
Left Brain, S2 4.46 ± 2.91 0.736 31.40 ± 5.03 0.654 
Right Brain, S2 6.92  ± 2.18 0.940 27.60 ± 7.03 0.783 
Left Brain, S3 3.05 ± 2.28 0.670 23.88 ± 2.89 0.895 
Right Brain, S3 5.94 ± 1.89 0.840 21.36 ± 8.80 0.601 
 
 
  
71 
 The influence of capillary veins can also modulate an orientation-dependent fL 
contrast in cortical gray matter (9). In (9) the influence of capillary deoxyhemoglobin on 
fL in rat brain in-vivo was carefully measured and found to be negligible relative to the 
bulk gray/white fL contrast (maximum ΔfL = 0.02 Hz for realistic values of oxygen 
saturation, Y = 0.7, and hematocrit, Hct = 0.4, in rat brain capillary). Close examination 
of our myelin-stained slides (see e.g. Fig. 4.5a) in the cortical ROIs, revealed the 
presence of striated myelin variation across the length of the  cortex but no clear evidence 
of larger capillary veins. For these reasons, we believe that capillary-mediated fL shifts 
negligibly contributed to the cortical gray matter orientation-dependent fL variations 
observed in this study. 
 The orientation dependence of fL was also evaluated in sub-cortical gray matter. 
Four ROIs were chosen in the left and right brain lateral habenular nuclei (Fig. 4.2i). No 
distinct orientation dependence for fL (Fig. 4.2k) was observed. This result is similar to 
the orientation dependence of R2* in sub-cortical gray matter and distinct from fL of 
cortical gray matter which does show a subtle orientation dependence (Fig. 4.2g). This 
indicates the local frequency shift is sensitive to cellular architectural differences in 
different gray matter regions. 
Fig. 4.2h and l identify linear relationships between the orientation dependencies of 
R2* and  fL for cortical and sub-cortical gray matter. For cortical gray matter, R2* = 0.82·fL 
+ 49.27, while for sub-cortical gray matter, R2* = 1.10·fL  + 39.51. These linear relations 
identify the contribution of the local frequency shift to R2* through the R2′ value. Two 
scaling relations were found: R2′ = 0.82·fL  for cortical gray matter and R2′ = 1.10·fL for 
sub-cortical gray matter. The scaling constant relating R2′ to fL in cortical gray matter 
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(0.82) was 3.57 times larger than that of white matter (0.23). However, the mean 
amplitude of the fL variation in white matter is approximately 20 times larger than that of 
cortical gray matter (ΔfL = 4 Hz for white matter, compared to ΔfL = 0.2 Hz for gray 
matter). Together, these factors indicate that the orientation-dependent, reversible 
component of the transverse relaxation rate (R2′= constant · fL ) is approximately 5.60 
times larger in white matter as compared to gray matter (for the case of this fixed rat 
brain tissue). This R2′ difference is a function of the tissue microstructure because it is a 
function of both axonal density and fiber orientation dispersion inside a voxel (15).  
 The measurement of local frequency shift through unwrapping the phase, then, 
serves as an approximate alternative for measuring the orientation-dependent part of  R2′ 
in gray matter. This may be useful for probing changes in microstructure of gray matter 
associated with disease.  
4.4.6 Comparison of ΔχGLModel to Δχdipole in white matter 
The histograms in Fig. 4.3a and 3b compare ΔχGLModel to Δχdipole for each sample in each 
hemisphere. Table 4.4 shows the white matter susceptibility values calculated from fitting 
the GL model and associated Pearson correlation values. A Welch’s two-tailed t-test 
revealed that the GL model-derived and the inversion-calculated values of magnetic 
susceptibility in the external capsule were different (p < 0.05) in all cases, except for the 
right hemisphere of sample 3, where the mean value of ΔχGLModel is still larger than that 
of Δχdipole. The difference between these two measurements was, on average, 12.73 ± 
2.91 ppb. This difference results from the fact that the GL model accounts for the 
geometry-induced frequency shift of cylindrical axons, whereas dipole fitting does not.  
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 The magnitude of the isotropic component of the frequency shift in white matter 
is affected by formalin fixation. Recent research (30) conducted using excised rat brain 
 
Figure 4.3: Comparison of Δχdipole (black bars) to  ΔχGLModel (white bars) for both white 
matter (Fig. 4.3a and b) and gray matter (Fig. 4.3c and d). All susceptibility values are in 
SI units of parts-per-billion (ppb) and have been referenced to the susceptibility of gray 
matter in an adjacent ROI. Separate comparisons were performed for left and right brain 
hemispheres. Error bars represent standard error of the mean. Statistical significance 
levels are defined as: * p < 0.05 and ** p < 0.001.  
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optic nerve embedded in water suggests that the amplitude of this isotropic frequency 
shift is increased (this is a diamagnetic shift) by a factor of approximately two, due to 
fixation. For this reason, the isotropic frequency shifts reported in our paper may be 
larger than those observed in fresh rat brain tissue. 
 The GL model does not account for susceptibility variations in white matter due 
to either chemical exchange or myelin bilayer anisotropy. Nevertheless, it is a useful 
model that can improve estimates of susceptibility, provided the fiber angle relative to B0 
is known. Interestingly, the difference of 12.73 ± 2.91 ppb between ΔχGLModel and Δχdipole 
is on the order of the isotropic magnetic susceptibility of white matter recently calculated 
in mouse brain using susceptibility tensor imaging (13 ppb reported in reference (6)).  
These convergent results suggest that fitting the GL model to fL measured at multiple 
brain orientations is a robust technique for quantifying the isotropic, geometry-derived 
component of susceptibility in white matter.  
4.4.7 Gray matter 
The histograms in Fig. 4.3c and d compare ΔχGLModel  to Δχdipole for gray matter in each 
rat brain hemisphere. The values computed for ΔχGLModel and the associated Pearson 
correlation coefficients are listed in Table 4.4. A Welch’s two-tailed t-test showed that 
ΔχGLModel  and Δχdipole are the same in all ROIs (p > 0.05 in all cases). This is not 
unexpected, since the observed variation in fL with cortical fiber orientation in this study 
is very subtle (average amplitude of 0.56 ± 0.13 Hz for all ROIs examined).  
 From the above result, it can be inferred that, when gray matter susceptibility 
information is reconstructed using dipole inversion at standard clinical field strengths and 
resolutions of 1 mm3 isotropic, it is unlikely the effects of cortical fiber geometry on Δχ 
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will be significant. But this may not always be true for small animal studies. As 
susceptibility mapping methods improve and the achievable spatial resolution increases, 
the ΔχGLModel  value could serve as a standard for measurements of Δχdipole in cortical gray 
matter. Such a target value would facilitate analysis of convergence in regularized dipole 
inversion methods of quantitative susceptibility mapping. 
4.4.8 Correlative Histology of MRI and Non-Haeme Iron in Rat Brain Basal Ganglia 
Histological staining was performed to investigate the relationship between iron 
concentrations in rat brain tissue and the susceptibility contrast parameters (R2* and 
Δχdipole). Currently, there is significant interest in using a combination of R2* and Δχdipole 
to assess none-haeme iron variations in human brain tissue (7, 26, 31). However, to date, 
most studies have performed correlations between MRI susceptibility parameters in-vivo 
and ex-vivo iron concentrations derived from literature (7). The quantitative relationship 
between iron concentration, as derived from OD of iron-stained slides, and both R2* and 
Δχdipole  in the same tissue structure has not been examined.  
 To isolate the influence of iron on R2* and Δχdipole, ROIs were chosen in rat basal 
ganglia regions containing high iron concentration and low myelin content. The ROIs 
were centered on the left lateral-habenular and medio-dorsal nuclei (black boxes in Fig. 
4.4a). A positive correlation (R = 0.637, p < 0.001, Fig. 4.4d) between R2* and iron OD 
was observed according to the linear relation R2* = 158.05·OD + 36.72. This relation is 
specific to the field strength used in this study (9.4 T) due to the dependence of R2* on 
field strength. A similar positive correlation was found between Δχdipole  and iron OD (R = 
0.465, p < 0.001, Fig. 4.4f) with the linear regression fit: Δχdipole = 674.05·OD – 79.3. R2* 
was also plotted against corresponding Δχdipole on a voxel-by-voxel basis (Fig. 4.4b) to 
  
76 
 
Figure 4.4: R2* and quantitative susceptibility values in the lateral-habenular and medio-
dorsal nuclei (deep brain basal ganglia structures) of the rat brain positively correlate 
with Fe3+ density from DAB-enhanced Perls staining. (a) A representative coronal section 
of a rat brain stained with DAB-enhanced Perls is shown. Black boxes indicate the ROIs 
in which OD and quantitative MRI values were measured. ROIs include the right and left 
lateral-habenular nuclei and the right and left medio-dorsal nuclei. The corresponding 
coronal MRI sections of a rat brain are displayed in (c) for R2* (in units of 1/s) and (e) for 
quantitative susceptibility (in units of ppb). Figure 4b displays a positive linear 
correlation between R2* and Δχdipole in the rat basal ganglia. The correlation of R2* (d) or 
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Δχdipole (f) with OD measurements are also shown. Each data point represents a voxel 
from the chosen ROIs. The black dotted lines indicate the linear regression fit to the data. 
R and p values are indicated in the top left corner of the correlation plots. 
 
derive a relationship between these parameters for Fe3+ iron at 9.4 T. The linear relation 
between R2* and Δχdipole was R2* = 0.10·Δχdipole + 49.59, with R = 0.447 and p < 0.001. 
We observed a linear correlation between R2* and Δχdipole in the rat basal ganglia         
(Fig. 4.4b). In general, these two parameters need not be correlated (32); thus, this 
observation sheds some light on the underlying mechanisms governing these two 
quantities. Inter-voxel susceptibility differences can result in a positive or negative 
frequency shift between voxels without contributing to the R2* of these voxels, while 
increased intra-voxel susceptibility variation can lead to incoherent dephasing and 
increased R2* in a voxel. For the case of the basal ganglia, our data suggests that punctate 
non-haeme iron concentrations in the brain are accompanied by magnetic field 
inhomogeneities on the scale of the voxel, thus affecting both R2* and Δχdipole. 
4.4.9 Correlative Histology of MRI and Myelin Density in Rat Brain Major White 
Matter Regions 
In Fig. 4.5, the effect of myelin density on C0 and C1 was examined. The specific ROIs 
used for this analysis are given by the black boxes in Fig. 4.5a and b. They include dense 
white matter regions of the corpus callosum, external capsule and internal capsule. C0 and 
C1 showed strong positive correlations with myelin OD (Fig. 4.5c and e). C0 was 
correlated with myelin OD according to the relation C0 = 64.96·OD + 37.84, with R = 
0.905 and p < 0.001 (Fig. 4.5c). C1 was correlated with myelin OD according to the 
relation C1 = 1.62·OD + 0.94, with R = 0.456 and p < 0.001 (Fig. 4.5e). C0 and C1 were  
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Figure 4.5: The constants, C0 and C1, derived from the linear R2* orientation model 
correlate positively with OD of solochrome cyanine-R staining for myelin in both major 
white matter tracts and cortical gray matter. (a) A representative coronal section of the rat 
brain stained for myelin. (b) R2* map corresponding to the myelin stain. Black boxes 
indicate the ROIs in which the OD of myelin, C0 and C1 were measured in white matter. 
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Green boxes indicate the ROIs in which the OD of myelin, C0 and C1 were measured in 
cortical gray matter. C0 (c,d) and C1 (e,f) correlated positively with the myelin OD in 
major white matter tracts and cortical gray matter.  Each data point represents a voxel 
from the chosen ROIs. (g,h) Linear relations between the value of C1, calculated from 
fitting the linear R2* model, and Δχ, calculated from the GL model for both white (g) and 
gray (h) matter. C1 and Δχ are related through Eq. 4.3. The OD was used as a surrogate 
for the volume fraction (ζ) of perturbers in these plots.  
 
also computed in six ROIs lining the cortex (green boxes in Fig. 4.5a and b). C0 and  
C1 both demonstrated strong positive correlations with myelin OD in these regions         
(Fig. 4.5d and f). This supports our hypothesis that an orientation dependent R2* exists in 
the cortex and the source of this dependence is associated with cortical fibers. 
 It is noteworthy that R2 (Co) and R2′ (C1) are affected in different ways by 
changes in myelin density. R2 is governed by spin-spin interactions between 
neighbouring hydrogen atoms, while R2′ is mediated by mesoscopic magnetic field 
gradients both inside and between voxels. The linear relations derived from the plots in 
Fig. 4.5 can be used to independently estimate myelin concentration given either R2 or 
R2′. As well, they support the concept that myelin density and axonal geometry are two 
major factors governing R2* changes observed with changes in fiber orientation.  
 According to Eq. 4.3, the constant C1, derived from fitting the linear model to the 
R2* orientation data, is a linear function of Δχ. To test the validity of this model in both 
white and cortical gray matter, a value of Δχ was calculated in the black and green ROIs 
shown in Fig. 4.5a and b, using the GL model. The parameters C1 and OD were then 
calculated in these ROIs. The OD value calculated in the ROIs was used as a measure of 
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C1 and Δχ. In white matter a significant linear correlation was observed, verifying that 
OD can serve as a surrogate marker for perturber volume fraction. However, in cortical 
gray matter the correlation was not significant, likely due to the poorer fitting of the GL 
model on a voxel-by-voxel basis in gray matter (as opposed to the case of a single mean 
value from an ROI shown in Fig. 4.2g). To the best of our knowledge, this is the first 
demonstration of the use of OD as a surrogate marker for volume fraction in white matter 
microstructure analysis, as well as the first demonstration of a relationship between R2*  
and Δχ based on the isotropic perturber model. These results suggest that, for white 
matter, the combined use of R2*, Δχ and OD derived from histochemical staining can 
enhance knowledge of underlying tissue composition. 
 
4.5 Conclusion 
This study demonstrates a significant orientation-dependence of R2* in both white and 
cortical gray matter that is a sinusoidal function of tissue orientation and a linear function 
of perturber volume fraction. The fitting coefficients, C0 and C1, calculated using the R2* 
cylindrical field perturber model, are linearly related to myelin density. For white matter, 
the isotropic perturber fraction, C1 , is a linear function of the white matter susceptibility 
difference (Δχ) relative to gray matter. This finding supports the premise that a major 
underlying source of the orientation dependence of R2* is the axonal geometry-derived 
susceptibility shift. 
 A comparative analysis of the orientation dependencies of R2* and fL in matched 
tissue locations throughout the rat brains allowed calculation of scaling relations which 
quantify R2′ given  fL. Using these relations, the orientation-dependent, reversible 
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component of the transverse relaxation rate (R2′= constant · fL ) was found to be 
approximately 5.60 times larger in white matter compared to gray matter. Measuring such 
differences in R2′ in different brain tissues is a potential method for probing tissue 
microstructure, since R2′ is a function of the geometry-derived, frequency dispersion 
within a voxel. Equally relevant, the identification of optical density of myelin staining as 
a realistic surrogate for volume fraction in white and cortical gray matter may 
complement future studies relating biophysical models of the MRI signal to true 
underlying tissue composition.  
 The next chapter highlights a 7 T imaging study using whole-brain, quantitative 
Δχ and  R2* mapping for simultaneous monitoring of iron deposition and demyelinating 
processes in MS patients. 
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Chapter 5 
Improved Identification of MS Disease-Relevant Changes in Gray 
and White Matter using Susceptibility-Based High Field MRI 
 
To make a discovery is not necessarily the same as to understand a discovery.  
– Abraham Pais, Inward Bound: of Matter and Forces in the Physical World. 
 
5.1 Introduction 
Conventional magnetic resonance imaging (MRI) measures of MS disease status, using 
the number and location of lesions in white matter (WM), have not correlated well with 
clinical symptoms (1) or demonstrated significant predictive power for determining 
disease progression (2). On the other hand, neuropathological studies have identified the 
following features as being strongly related to MS etiology and neurodegeneration: (i) 
changes in the chemical composition of myelin, (ii) axonal loss and (iii) accumulation of 
iron in brain regions affected by MS (3). Unfortunately, it has been difficult to quantify 
such neuropathological markers in vivo using standard MRI contrasts. The goal of this 
study was to explore the use of quantitative susceptibility-based MRI at 7T to identify 
characteristic regions suggestive of demyelination and increased iron deposition in MS 
patients and relate these measurements to patient disability.  
 For the purposes of this research, quantitative susceptibility-based MRI consists 
of the measurement of the apparent transverse relaxation rate (R2* = 1/T2*) and local 
Larmor frequency shift (LFS) using a straightforward multi-echo gradient echo (GRE) 
sequence. In brain tissue of MS patients, R2* values are affected by focal accumulation of 
iron, as well as by transient demyelination and remyelination (4, 5). For this reason, R2* 
has been proposed as a surrogate biomarker of disease severity (4). However, R2* maps 
  
87 
can be inaccurate at tissue interfaces where steep magnetic field gradients exist (6). 
Additionally, elevated concentrations of iron and myelin both increase R2*. This makes it 
difficult to attribute R2* increases to either iron accumulation or re-myelination alone. 
Disentangling the contributions of myelin and iron to the R2* signal would make it more 
valuable for understanding MS pathophysiology. 
  Quantitative susceptibility (QS) mapping (7-9) is an MRI technique 
complementary to R2* mapping that calculates tissue volume magnetic susceptibility from 
the LFS. It advantageously removes the effects of confounding non-local magnetic fields 
created by tissue boundaries. It is also differentially sensitive to myelin and iron (8). 
Increases in myelin content (e.g. due to re-myelination) negatively shift the absolute QS 
value because myelin is diamagnetic, while increases in iron content positively shift QS 
because iron is paramagnetic (8). Because of this differential sensitivity, QS has the 
potential to more precisely monitor disease-related changes in MS. Accordingly, the 
combined use of QS and R2* obtained from multi-echo GRE MRI has been advocated as 
a comprehensive method for studying brain tissue composition due to the differing 
sensitivities of QS and R2* to iron and myelin (10, 11).  
 In this work, we used QS mapping in conjunction with mono-exponential, R2*-
based relaxometry to evaluate voxel-wise WM changes associated with MS disease 
severity. Such a multi-parametric comparison in white matter has not previously been 
performed. As a natural extension of the WM analysis, QS and R2* were also used for 
monitoring iron accumulation in sub-cortical gray matter. Localization and quantification 
of sub-cortical iron has the potential to enhance our understanding of the progressive loss 
of neuronal function, motor deficits and cognitive impairment which accompany MS 
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disease progression (12).  
  In summary, the purpose of this study was to evaluate the potential of quantitative 
susceptibility (QS) and apparent transverse relaxation rate (R2*) mapping as surrogate 
biomarkers of clinically relevant, age-adjusted  demyelination and iron deposition in MS 
patients.  
 
5.2 Materials and Methods 
5.2.1 Imaging Protocol  
Informed consent was obtained from a population of 25 patients with either CIS (four 
patients) or RRMS (21 patients), as well as from 15 healthy, age and gender-matched 
volunteers. The research was approved by the Research Ethics Board of the University of 
Western Ontario. All subjects gave written consent. The mean age of patients was 37.3, 
with ages ranging from 21 to 45. Patients had Kurtze Extended Disability Status Scale 
scores (EDSS scores) extending from 0 to 6. All CIS patients had an EDSS of 0. Further 
information characterizing the patient cohort is listed in Table 5.1 on the following page.  
 Imaging was performed on a 7 T neuro-specialized MRI scanner (Agilent 
Technologies, Santa Clara, California) using 16  parallel transmit channels and either 16 
or 23 channel receive coils. Main external magnetic field (B0) (13) and radiofrequency 
transmit field (B1+) shimming (14) were performed on each subject prior to acquisition of 
the following sequences: (i) a 3D multi-echo GRE sequence (0.5 × 0.5 × 1.25 mm3 
resolution) to obtain susceptibility-based images (ii) a T2-weighted, magnetization-
prepared (MP)-FLAIR sequence (1.0 × 1.0 × 1.0 mm3 resolution) for lesion delineation  
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Table 5.1: Demographic and Clinical Data. Demographic and clinical data for study 
cohort. All data showing error estimates represent mean ± standard deviation. P-values 
were computed using a Wilcoxon rank-sum test. 
 
Variable Controls Patients p-value 
Number of Participants 15 25 Not applicable 
Gender, M/F 3/15 7/25 Not applicable 
Age 36.4 ± 6.42 37.3 ± 6.10 0.58 (Not significant) 
EDSS score * Not applicable 1.70 (0 – 6) Not applicable 
 
* Data in parentheses represent range of EDSS scores for all patients. 
 
(total scan time = 12 minutes and 1 second) and (iii) a T1-weighted, MPRAGE 
acquisition (1.0 × 1.0 × 1.0 mm3 resolution) for anatomical reference and use in tissue 
segmentation (total scan time = 5 minutes and 45 seconds). The multi-echo GRE 
sequence used the following pulse sequence parameters: axial orientation, TR=40 ms, 
TE1=3.77 ms, number of echoes=6, echo spacing=4.09 ms, flip angle=13°, matrix 
dimensions=380×340× 102, GRAPPA acceleration factor R=2 along the first phase 
encode direction, in-plane resolution=0.5x0.5 mm2, slice thickness=1.25 mm, field of 
view=190×170×128 mm3, total scan time=15 minutes and 55 seconds. 
5.2.2 Calculation of R2*, LFS and QS maps 
From the multi-echo GRE magnitude data, mono-exponential R2* maps were generated 
using an interior-point, least squares fitting routine in Matlab (R2013, The MathWorks, 
Natwick, MA, USA). To compensate for the influence of confounding background field 
gradients, T2*-weighted magnitude data was corrected prior to least squares fitting 
according to the method outlined in references (6, 15).  
For QS map calculation, raw phase images were temporally unwrapped along the 
echo train. Residual phase wraps were then removed in three-dimensions using a region-
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growing algorithm (16). Background field contributions were subsequently removed by 
employing the sophisticated harmonic artifact reduction for phase data method (SHARP) 
(8) with a spherical kernel radius of 7 mm to generate an LFS map. The QS map was 
calculated from the LFS map by employing a k-space based, regularized inversion (7) in 
Matlab. Accurate and reproducible QS mapping requires calculation of QS values relative 
to a common reference structure. In this study, bilateral regions of interest (ROIs) in 
frontal deep WM were used as a reference tissue (10).  
5.2.3 Voxel-Wise Statistical Analysis 
 Voxel-wise statistical analysis was performed by registering the calculated R2* 
and QS maps to the MNI-1 mm template using a non-linear registration with the FNIRT 
tool in FSL (17).  A general, additive linear model (GLM) was then applied to evaluate 
statistically significant changes in both R2* and QS on the voxel level. Age was included 
as a covariate in the linear model. No interactions between covariates or between groups 
were modeled. This was done because the inclusion of interactions in the GLM did not 
result in improved fitting of the model to the data. All resulting Z-score maps were 
corrected for multiple comparisons using the false-detection-rate technique (18) and 
thresholded to include Z-scores with |Z| > 1.0. This threshold was applied to allow for the 
visualization of both trends and statistically significant regions in the Z-score maps. The 
GLM analysis was also performed with WM lesions removed in order to identify 
statistically significant reductions in QS and R2* in the normal-appearing white matter 
(NAWM) of MS patients. All image analysis was performed by MRI physics researchers 
experienced in neuroimaging and blinded to the clinical information (D.R. and R.S.M., 
with 5 and 33 years respectively, of experience in clinical neuroimaging).  
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 To investigate the correspondence between damaged WM in the Z-score maps 
and MS clinical disease status, the volume of damaged WM satisfying a Z<-2.0 criterion 
for both QS and R2* was correlated with three MS clinical metrics: extended disability 
status scale (EDSS), time since CIS diagnosis (TSCIS) and time since MS diagnosis 
(TSMS). This correlation analysis was performed with and without lesions. The Z<-2.0 
criterion has recently been used in the segmentation of “diseased-appearing white matter” 
from 2D, T2-weighted FLAIR images of MS patients acquired at 1.5T (19). Also, to 
explore possible associations between volume of tissue with elevated iron content and 
MS clinical status, the volume of sub-cortical gray matter with Z>2.0 was correlated with 
the three MS clinical metrics. 
 As well as using VBM, we evaluated changes in mean value of R2* and QS in 
four sub-cortical GM structures (caudate nucleus, putamen, globus pallidus and 
thalamus). Specifically, the strength of univariate correlations between the R2* and QS 
signals and the three MS clinical metrics were quantified. To account for age-dependent 
increases in these parameters, the effect of age was subtracted from R2* and QS data by 
calculating the slope in a regression of both R2* and QS as a function of age for the 
controls. All sub-cortical gray matter segmentation masks were calculated using the FSL 
FIRST tool (17) applied to the bias-field corrected, T1-weighted magnitude images.    
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5.3 Results 
5.3.1 Representative 7 T Image Contrasts and Template Registration Examples 
Representative images from a 45-year old, female RRMS patient with an EDSS score of 
1.0 are displayed in Figure 5.1 on the following page. The top row (A-C) shows the 
anatomical contrasts: (A) T1-weighted MPRAGE, (B) T2-weighted MP-FLAIR and (C) 
T2*-weighted magnitude image. The bottom row (D-F) presents susceptibility-based MRI 
contrasts of the same slice: (D) R2*, (E) LFS and (F) QS maps. Magnified views of a 
periventricular WM lesion are displayed in red boxes in the top right hand corner of each 
figure. The magnified views of the lesion in Figure 5.1D - F identify deoxyhemoglobin-
bearing vessels, hyperintense on the R2*-map and hypointense on the LFS map. These are 
not visible on the T1- or T2-weighted contrasts. Also visible within the lesion are uniquely 
heterogeneous regions of decreased R2* and increased LFS, representing possible edema 
or demyelination. 
 Examples of group-averaged, R2*, LFS and QS maps registered to the MNI-1 mm 
template space are presented in Figure 5.2 on page 94. The yellow arrows in Figures 5.2A 
and B point to slices through the caudate and globus pallidus where increased R2* is 
visible in the group-averaged patient maps compared to corresponding control maps. The 
red arrows in Figures 5.2E and F identify areas with reduced absolute values of QS in the 
optic radiations of the group-averaged control maps compared to corresponding slices in 
MS patients.   
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Figure 5.1: Representative MR image contrasts employed in this study. MR images 
corresponding to one slice from a 45-year old RRMS patient with an EDSS score of 1.0. 
Top row: (A) T1-weighted MPRAGE, (B) T2-weighted MP-FLAIR contrasts and (C) a 
T2*-weighted magnitude image. Bottom row: (D) R2*, (E) LFS and (F) QS maps. 
Magnified views of a lesion in the periventricular white matter are shown in the red 
boxes (top right hand corner of each figure).  
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Figure 5.2: Standard space, susceptibility-based MRI contrasts. Examples of non-
linearly registered R2* (Figure 5.2A and B), LFS (Figure 5.2C and D) and QS (Figure 
5.2E and F) group-averaged maps in the MNI-1 mm template space. Yellow arrows in 
Figure 5.2A and B identify regions of the caudate nucleus and globus pallidus of MS 
patients with increased R2*. Red arrows in Figure 5.2E and F display regions with 
reduced absolute values of QS in the optic radiations of the group-averaged control maps 
compared to corresponding slices in MS patients. 
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5.3.2 ROI-based analysis of R2* and QS in sub-cortical gray matter structures 
Representative sub-cortical nuclei segmentations overlaid on the T1-weighted image are 
displayed in figure 5.3. Figure 5.4 on the following page illustrates that, in all the 
segmented sub-cortical gray matter structures, both age-corrected R2* and QS showed 
very strong positive correlations (p<0.01) with EDSS. The mean R2* value in the 
thalamus and caudate displayed the strongest linear correlations (R=0.57). For QS 
mapping, the globus pallidus exhibited the strongest linear correlation with EDSS 
(R=0.70). Each data point in Figure 5.4 represents the mean value of R2* or QS in a 
particular sub-cortical gray matter structure. Separate data points are plotted for the left 
and right brain hemispheres, while the red crosses correspond to the mean values of the 
control group.  
                                 
Figure 5.3: Sub-cortical nuclei segmentations overlaid on the T1-weighted image. 
Labels for the left side of the brain are coloured white, while labels for the right side are 
coloured gray. Segmentation masks are shown for left and right brain caudate (1 and 2), 
putamen (3 and 4), globus pallidus (5 and 6), and thalamus (7 and 8). Segmentation 
masks which bled into the ventricles were removed by thresholding of R2* and QS maps. 
 
 Table 5.2 on page 97 compares group mean values of R2* and QS in sub-cortical 
gray matter to those of controls. The mean R2* of patients increased relative to controls in 
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all structures, with the exception of the globus pallidus. The most significant increase in 
R2* was observed in the putamen (p<0.001, ΔR2* = 3.80 ± 0.74 1/s). The mean QS value 
was also increased compared to controls at the level p<0.008 and below.  
 
Figure 5.4: Scatter plots of R2* and quantitative volume magnetic susceptibility in 
MS patients with respect to Expanded Disability Status Scale (EDSS). Each data 
point represents the mean value of the quantitative MRI parameter inside one of the 
following structures: (A)  caudate nucleus, (B) putamen , (C) globus pallidus and (D) 
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thalamus. A separate data point is displayed for each hemisphere in each patient. The red 
lines represent the mean values of the control group.  
 
The most significant increases in sub-cortical QS were found in the thalamus (p<0.001, 
ΔQS = 11.47 ± 4.54  ppb) and globus pallidus  (p<0.001, ΔQS =  13.02 ± 5.09 ppb). 
 Table 5.3 on page 100 compares the strength of univariate correlations between 
sub-cortical R2* and QS  and the three MS clinical metrics (EDSS, TSCIS and TSMS). 
Sub-cortical gray matter R2* and QS most strongly predicted EDSS. However, 
associations with TSCIS were found for R2* of the caudate (R=0.40, p<0.01) and globus 
pallidus (R=0.47, p<0.001), as well as for QS in the putamen (R=0.38, p<0.01) , globus 
pallidus (R=0.42, p<0.01) and thalamus (R=0.47, p<0.031). TSMS was independently 
predicted by R2* of the globus pallidus (R=0.39, p<0.01),  as well as by QS of the 
putamen (R=0.35, p=0.01)  and thalamus (R=0.30, p=0.04). 
  
Table 5.2: Sub-Cortical Gray Matter Mean Values of Susceptibility-Based MRI 
Parameters Compared to Controls. Mean quantitative R2* and susceptibility in the sub-
cortical GM regions of MS patients compared to healthy, age and gender-matched 
controls. All values are mean ± standard error.  
 
Sub-cortical GM Structure Controls Patients p-value 
Caudate R2* (1/s) 44.52 ± 2.30 46.93  ±  0.79 0.001 
Putamen R2* (1/s) 46.31 ± 0.43 50.11  ±  0.60 < 0.001 
Globus Pallidus R2* (1/s) 89.88 ± 1.47 90.65  ±  1.18 0.31 
Thalamus R2* (1/s) 39.32 ± 1.73 43.55  ±  0.81 0.004 
Caudate QS (ppb) 39.71 ± 2.36 45.43 ± 1.44 0.003 
Putamen QS (ppb) 33.65 ± 1.01 42.14 ± 2.07 0.008 
Globus Pallidus QS (ppb) 128.49 ± 2.73 141.51  ±  4.30 < 0.001 
Thalamus QS (ppb) 25.85 ± 4.03 37.32  ± 2.10 < 0.001 
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5.3.3 Voxel-wise analysis for evaluating differences in QS and R2* in MS patients 
compared to controls 
Figure 5.5 on the following page displays axial-plane, R2*-based, Z-score maps at the 
level of the sub-cortical gray matter (Figure 5.5A-C), supratentorial brain (Figure 5.5D-F) 
and cortical WM (Figure 5.5G-I). Positive Z-scores (orange/red/yellow areas) in sub-
cortical gray matter suggest elevated non-haeme iron in patients compared to controls 
(10, 20). Blue colours represent brain regions with significantly (Z<-1.0) reduced R2* in 
white matter lesions. Green colours represent brain regions of patient NAWM with 
significantly reduced R2* suggestive of pre-lesional demyelination. Reduced R2* in WM 
could also be caused by decreased non-haeme iron in glial cells (21) or by a reduced 
overall metabolic demand for oxygen in the capillaries of damaged WM (22). If present, 
either of these effects would lead to a slight overestimation of the demyelination response 
we observed in our R2*-based Z-score maps. An alternative hypothesis, which is 
supported by recent MRI studies of reduced cerebral blood flow in MS (23, 24), is that 
slower blood flow and concomitantly increased oxygen exchange in capillaries could 
result in increased R2* in WM. If this effect were present, the demyelination effect we 
observe would be underestimated (section 5.3.3 is continued on page 100).  
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Figure 5.5: R2*-based, axial Z-score maps. R2*-based, axial Z-score maps derived from 
generalized linear model analysis of 25 patients compared to 15 age-matched controls. 
Blue colours represent brain regions with significantly reduced R2* (Z<-2.0) in lesioned 
tissue of patients compared to controls. Green colours represent brain regions of patient 
normal-appearing white matter (NAWM) with significantly reduced R2* (Z<-2.0) 
compared to controls. Red/orange areas with positive Z-scores indicate brain regions 
where patients have higher R2* (Z > 2.0) than age-matched controls. (A-C) are three 
representative slices through the sub-cortical GM, (D-F) are three representative slices 
through the periventricular white matter and (G-I) are three representative slices through 
the cortical white matter. All Z-score maps were corrected for multiple comparisons 
using the false-detection-rate technique with a significance threshold of 0.1. 
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Table 5.3: Correlations between susceptibility-based MRI parameters and clinical 
metrics. Pearson linear correlation between mean MRI-derived susceptibility parameters 
in sub-cortical gray matter and MS clinical metrics (time since CIS diagnosis = TSCIS, 
time since MS diagnosis = TSMS). The MRI susceptibility parameters were corrected for 
age-related increases in iron. Data in parentheses are P values. 
 
MRI-Derived Parameter EDSS TSCIS TSMS Age 
Caudate R2* (1/s) 0.57 (< 0.01) 0.40 (< 0.01) 0.19 (0.18) 0.37 (0.05) 
Putamen R2* (1/s) 0.39 (< 0.01) 0.21 (0.14) 0.03 (0.86) 0.48 (0.01) 
Globus Pallidus R2* (1/s) 0.50 (< 0.01) 0.47 (< 0.001) 0.39 (< 0.01) 0.52 (< 0.01) 
Thalamus R2* (1/s) 0.57 (< 0.01) 0.20 (0.15) 0.06 (0.69) 0.25 (0.21) 
Caudate QS (ppb) 0.44 (< 0.01) 0.17 (0.24) 0.06 (0.70) 0.19 (0.32) 
Putamen QS (ppb) 0.58 (< 0.001) 0.38 (< 0.01) 0.35 (0.01) 0.39 (0.03) 
Globus Pallidus QS (ppb) 0.70 (< 0.001) 0.42 (< 0.01) 0.21 (0.14) 0.59 (< 0.001) 
Thalamus QS (ppb) 0.56 (< 0.001) 0.47 (< 0.001) 0.30 (0.04) 0.28 (0.23) 
 
 Due to the somewhat conflicting findings in the literature, it is not entirely clear 
which direction the white matter venous R2* should shift in MS due to the BOLD effect. 
However, we can make an informed estimate of the amplitude of the BOLD-mediated R2* 
changes by referring to the work of Jochimsen et al. (25). Using Monte-Carlo simulations 
to model T2* relaxation in cerebral venous vasculature, Jochminsen demonstrated that, for 
typical white matter vessels with radii of 4 – 32 µm,  R2* changes due to hypercapnia 
(which approximates the ‘hypometabolic’ state observed in MS) are expected to be on the 
order of 0.2 s-1. Such changes are very small compared to the average R2* difference in 
white matter we observed between MS patients and controls (5.95 ± 0.73 s-1 ; including 
lesions). Based on this  estimate, the BOLD-mediated venous R2* changes are not 
believed to have significantly affected our results. 
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 Two additional factors, derived from the existing literature, suggest the changes 
we observed in the R2*-based Z-score maps can be attributed to demyelination.  First, the 
patterns of negative Z-scores follow the major WM bundles in the same manner as voxel-
wise maps obtained from myelin-water fraction (MWF) (19, 26) and diffusion-weighted 
fractional anisotropy (FA) (27) measurements in MS patients. Since MWF and FA are 
principally sensitive to myelin structure in WM (not iron), these similar patterns point to 
myelin as the major biological source of the reduced R2*. Secondly, there is mounting 
evidence from post-mortem histochemical staining of both healthy (28) and MS NAWM 
(29) that phospholipid bilayer components are the major source of disseminated signal 
decreases observed on transverse relaxometry-based (R2* and R2) MRI.  
 The damage to NAWM (green areas) occupies a subset of the total (lesion + 
NAWM) WM damage. It is localized to the genu, body and splenium of the corpus 
callosum, as well as to the optic radiations and periventricular WM. NAWM damage is 
also clearly observed in the cortical WM. Although age was included as a covariate, no 
significant, voxel-level age effects for R2* were observed at a false-detection rate 
threshold of 0.1.   
Figure 5.6 demonstrates axial-plane, QS-based Z-score maps through the mid-
brain (Figure 5.6A-C), supratentorial brain (Figure 5.6D-F) and cortical WM (Figure 
5.6G-I). Since myelin is a diamagnetic perturber which negatively shifts raw QS values 
(i.e. heavily myelinated tracts are more diamagnetic), demyelination results in a decrease 
in the QS values relative to frontal WM. Blue areas in Figure 5.6 represent lesioned 
tissue, while green areas represent damage to NAWM. In Figure 5.6D and E, 
significantly (Z<-1.0)  reduced Z-scores are visible in the genu and splenium of the 
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corpus callosum adjacent to the ventricles. In the superior cortical WM (Figure 5.6G-I), 
disseminated regions of reduced Z-score are identified along the midline of the brain. As 
was the case for the R2*-based Z-score maps, the NAWM damage highlighted in green 
occupies a subset of the total damage. The total volume of NAWM damage with Z<-2.0 
for QS was significantly larger than that observed for R2*: the mean (per patient) NAWM 
damaged volume from QS was 2126 mm3 but only 175 mm3 from R2*. This suggests that,  
for our chosen gradient echo scan parameters, QS may be more sensitive to the full extent 
of NAWM damage which precedes lesion formation in MS patients.   
 Bilateral, statistically significant increases in the QS of patients were observed at 
the level Z>2.0 in the globus pallidus and putamen in Figure 5.6A and B. Such increases 
were not seen on the corresponding R2*-based maps, suggesting QS was prefentially 
sensitive to MS pathology-related iron accumulation in these areas. Figure 5.6B and C 
also reveal evidence of statistically significant increases in QS values in the thalamus, 
with a particular localization of high Z scores in the pulvinar nucleus.  
 Figure 5.7 shows axial-plane, Z-score maps illustrating the change in QS as a 
function of patient age. Blue areas indicate regions of significant QS decrease as a 
function of age, while orange/red areas represent regions of significant QS increase as a 
function of age. WM lesions were not found to be co-localized with age-dependent QS 
reductions. Figure 5.7A-C demonstrate that QS increases significantly (Z>2.0) with age 
in the anterior portion of the globus pallidus in MS patients. Increases in QS with age are 
visible in the anterior section of the putamen. Figure 5.7D-I also delineate bilateral 
decreases in QS with age in the periventricular WM of the centrum semiovale in MS 
patients.  
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Figure 5.6: QS-based, axial Z-score maps. QS-based, axial Z-score maps derived from 
generalized linear model analysis of 25 patients compared to 15 age-matched controls. 
Blue colours represent regions of significantly reduced  QS (Z<-2.0) in lesioned tissue of 
patients compared to controls. Green colours represent regions of patient NAWM with 
significantly reduced QS (Z<-2.0) compared to controls. Red/orange areas with positive 
Z-scores indicate brain regions where patients have higher QS (Z > 2.0) compared to age-
matched controls. (A-C) shows increased Z-scores in the sub-cortical GM structures. (D-
F) display reduced Z-scores in the periventricular white matter. G-I displays decreased 
QS in cortical white matter (blue colours).  
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Figure 5.7: Changes in relative magnetic susceptibility as a function of age. These Z-
score maps were derived by including age as a covariate in the generalized linear model 
statistical analysis. Blue colours represent brain regions with significantly reduced QS 
(Z<-2.0) in NAWM of patients as a function of age. Red/orange colours represent brain 
regions with significantly increased QS (Z > 2.0) in patients as a function of age. (A-C) 
are three representative slices through the sub-cortical GM, (D-F) are three representative 
slices through the periventricular white matter and (G-I) are three representative slices 
through the cortical white matter. 
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5.3.4 Relationships Between QS and R2*–Based Z-score Maps and Clinical Disability 
The strength of univariate correlation between the volume of damaged WM (defined by a 
Z<-2.0 criterion) and EDSS is presented in Figure 5.8 and the corresponding list of 
correlations with clinical metrics is recorded in Table 5.4 on page 107. Each data point in 
Figure 5.8 represents a single patient, while red and blue points represent R2* and QS-
based Z-score correlations respectively. Figure 5.8A displays the correlation between 
total damaged WM volume (lesional + NAWM with Z<-2.0)  and EDSS. QS damaged 
WM volume correlated with EDSS at the level p=0.02 with R=0.46. However, R2* 
damaged WM volume did not increase with higher EDSS (R=0.04, p>0.01). Figure 5.8B 
shows the same correlations with WM lesions removed. The volume of QS damaged WM 
again correlated with EDSS (R=0.39, p=0.05) but the corresponding volume for R2* 
(R=0.12, p>0.01) did not.  The volume of damaged WM did not correlate with TSCIS or 
TSMS for either QS and R2*. However, the EDSS score was independently predicted by 
the volume of sub-cortical gray matter tissue in QS-based Z-score maps with Z>2.0.   
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Figure 5.8: Relationship between volume occupied by significant negative Z-scores 
and EDSS. Relationship between the volume occupied by significant negative Z-scores 
(as defined by a  Z<-2.0 criterion) and EDSS. Each point represents a single MS patient. 
Data is shown with lesions (A) and without lesions (B). Red and blue points represent R2* 
and QS-based Z-score correlations with EDSS respectively. Only the number of 
significant voxels measured by QS correlated with EDSS. 
 
5.4 Discussion 
In this paper we examined both R2* and QS mapping of whole brain MS patient white 
matter compared to age and gender matched controls using voxel-wise analysis in a 
standard template space. By doing so, we demonstrated that computation of the 
susceptibility contrasts obtained with gradient echo MRI is an effective method for 
quantifying demyelination-related changes in NAWM of MS patient brain. A significant 
feature of combined R2* and QS mapping is that a single scan can be used to 
simultaneously identify iron accumulation in sub-cortical gray matter and demyelination 
in major white matter areas. The 'clinico-radiological' paradox associated with MS (30) 
suggests that lesion number and total lesion volume in white matter obtained from 
standard imaging are not predictive of clinical disease status. However in this work, with 
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QS-based Z score maps, EDSS was independently predicted using the volume of 
damaged white matter analysis. We also identified clinically relevant correlations 
between mean QS and R2* in individual sub-cortical gray matter structures of MS patients  
 
Table 5.4: Relationships between volume of tissue occupied by significant voxels in 
R2* and QS-based Z-score maps and clinical metrics. Pearson linear correlation 
between the tissue volume occupied by significant Z-score voxels (either significantly 
positive, Z > 2.0, for sub-cortical gray matter or significantly negative, Z<-2.0, for white 
matter) and clinical metrics of MS. Data in parentheses are P values, time since MS 
diagnosis is abbreviated as TSMS, time since CIS diagnosis is abbreviated as TSCIS. 
 
Volume of Significantly 
Affected MS Tissue EDSS 
TSCIS 
 TSMS Age 
Sub-Cortical Gray Matter, R2* 0.26 (0.22) 0.01 (0.99) -0.18 (0.39) 0.27 (0.18) 
White Matter R2* 0.04 (0.84) 0.21 (0.32) -0.08 (0.67) -0.13 (0.53) 
White Matter R2* Without 
Lesions 0.12 (0.56) 0.22 (0.29) -0.05 (0.81) -0.10 (0.64) 
Sub-Cortical Gray Matter QS 0.52 (< 0.01) 0.26 (0.19) 0.22 (0.29) 0.50 (0.01) 
White Matter QS 0.46 (0.02) 0.23 (0.27) 0.21 (0.32) 0.30 (0.14) 
White Matter QS Without 
Lesions 0.39 (0.05) 0.16 (0.43) 0.18 (0.39) 0.25 (0.23) 
T2  Lesion Load 0.17 (0.61) 0.65 (0.03) 0.09 (0.79) -0.11 (0.74) 
 
and EDSS, TSMS and TSCIS.  The finding that group-averaged, mean sub-cortical QS 
values exhibited more pronounced statistical differences compared to R2* maps for the 
iron-bearing globus pallidus and putamen supports the specific use of QS as an improved 
surrogate biomarker of iron accumulation in MS.   
 In white matter, the correlation of QS negative Z-score volume (R=0.46, p=0.02, 
blue dots) with EDSS contrasted with the lack of correlation for R2* (R=0.04 , p>0.10, 
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red dots). This may reflect a greater specificity of QS to WM damage. One possible 
source of this increased specificity is that QS is more directly related to myelin 
composition because it reflects the degree to which myelin becomes magnetized when 
exposed to the main field. In contrast, increased intra-voxel susceptibility variation leads 
to incoherent dephasing which constitutes the main source of increased R2*.  
 In a previous study, Langkammer et al. (31) demonstrated that QS was more 
sensitive than R2* in monitoring iron accumulation in sub-cortical nuclei of patients with 
CIS and MS. Elevated iron levels were also observed in clinically-definite MS patients 
compared to those with CIS. However, voxel-wise analysis was not performed.  Nor did 
the aforementioned study examine clinical correlations with TSMS and TSCIS. In 
population studies, voxel-wise analysis can be very useful in assessing differences in 
specific brain locations between patients and controls. For this reason, we believe our 
findings have identified a new, viable analysis avenue for QS mapping of MS. For 
example, our results showed high positive Z-scores in the QS-based maps in the 
thalamus, with notably high values in the pulvinar nucleus. This result supports findings 
of a previous study by Lebel et al. (32) which noted the pulvinar demonstrated the largest 
percent change of all sub-cortical gray matter structures in MRI phase measurements. It 
further suggests iron accumulation in the thalamus is visible at the voxel level when using 
group analysis with 7T susceptibility mapping. The accumulation of iron in the thalamus 
may play a significant role in thalamic atrophy which has recently been associated with 
conversion to clinically definite MS (33).  
 The patterns of reduced R2* in our Z-score maps are consistent with a previous 
voxel-wise analysis which applied MWF to visualize pathological demyelination in 
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NAWM of primary progressive MS (PPMS) patients (26). The asymmetric decreases in 
the R2*-based Z-score maps in the left hemisphere optic radiations are consistent with 
asymmetric patterns of demyelination in the optic tract observed in CIS (30), MS (34) 
and in related demyelinating disorders such as progressive multifocal 
leukoencephalopathy (35).  The particular pattern of the asymmetric negative Z-scores 
we observed, however, is likely a group-average effect specific to our limited patient 
cohort. It is not believed to be a common trend across all MS disease sub-types and 
patient cohorts. The voxel-level, age-related decreases in our QS-based Z-score maps 
have not been previously reported and were not observed in controls. Larger-scale 
clinical studies of MS have independently confirmed that age, as well as duration of 
disease, correlate with worsening clinical symptoms (36-38). Our voxel-wise QS results, 
combined with the aforementioned clinical data, suggest there is a meaningful 
contribution of age to demyelination. With this in mind, age-adjusted EDSS or age-
adjusted TSMS as proposed in reference (36) may constitute more precise metrics for 
monitoring MS progression compared to the standard, non age-adjusted measures. The 
detection of age-related demyelination using QS, but not R2*, implies age-related myelin 
loss is more closely linked to magnetic susceptibility properties which govern QS (39) 
than to nuclear relaxation of hydrogen nuclei probed by R2*. 
 There are several limitations associated with our study. First, no MRI data was 
collected from the spinal cord because the 7T neuroimaging scanner employed for this 
work does not permit spinal cord imaging. Quantitative MRI of the spinal cord using 
magnetization transfer ratio and diffusion-weighted MRI has previously identified 
correlations with disability that reflect underlying damage to the central nervous system 
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(40). It follows that a future direction for related research should involve correlating 
susceptibility-based changes observed in the spinal cord at 1.5 or 3T with those observed 
in the brain at 7T. Additionally, the underlying biophysical sources of the combined QS 
and R2* contrast in MS still require further investigation using combined MRI and post-
mortem histopathological validation. Our results and the work of others (36-38) seem to 
support myelin as the dominant contributor to the QS signal in NAWM. However, further 
research is necessary to quantify the additional influence of iron dysregulation due to 
oligodendrocyte apoptosis and macrophage activation (21, 39) on the susceptibility 
contrasts in MS NAWM.  
 The relatively small size of our patient cohort is another limitation to this study. 
The statistically significant differences in the quantitative MRI parameters reported here 
should be verified in future work using a larger cohort of MS patients. Overall, our 
findings suggest susceptibility-based MRI would be useful for longitudinal monitoring of 
demyelination and remyelination in RRMS.  
 
5.5 Conclusion 
QS and R2* maps acquired using standard GRE MRI identify demyelination and iron 
accumulation in MS which correlate strongly with clinical disability. Using this 
information may allow earlier administration of therapies and monitoring of MS 
pathology in-vivo. Voxel-wise QS, rather than R2*, was preferentially sensitive to 
monitoring NAWM demyelination and sub-cortical iron accumulation in-vivo. The 
volume of damaged white matter tissue identified by QS was predictive of EDSS. The 
sensitivity of both QS and R2* mapping to total white matter (lesions + NAWM) damage 
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suggests these quantitative contrasts may be useful for long term monitoring of 
demyelination and remyelination in MS.   
 The sixth and final chapter briefly summarizes the research carried out for this 
thesis. It also suggests ways of extending this research, emphasizing both technical 
developments and clinical applications. 
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Chapter 6  
Conclusion and Future Directions 
The Journey is the Reward. 
– Steve Jobs, iSteve 
 
MRI is capable of producing images revealing a vast array of different tissue parameters 
(1, 2). Currently, for instance, MRI contrast can be preferentially sensitized to tissue 
relaxation properties (T1, T2 and T2*), microstructure (diffusion and susceptibility-based 
MRI) and motional properties (blood flow and water diffusion) (3). The work presented 
in this thesis has investigated the fundamental relationship between the susceptibility 
contrast parameters (R2*, LFS and Δχ) and underlying tissue structure. The research was 
carried out using biophysical modeling and correlation with quantitative histology. For 
the first time, multiple biophysical modeling schemes were compared in both gray and 
white matter for excised rat brain tissue. Additionally, scaling relations were derived for 
calculating the reversible, mesoscopic magnetic field component, R2′, of the apparent 
transverse relaxation rate from the orientation dependence in gray and white matter.  
 An optimal susceptibility processing pipeline was also developed and applied to 
the calculation of phase-combined LFS and QS maps obtained using ultra-high field 
(UHF) MRI. The processing pipeline was then utilized to monitor myelin and iron 
changes in MS patients compared to healthy, age and gender-matched controls by 
employing voxel-wise analysis in a standard template space. With the use of QS and R2* 
mapping, evidence of statistically significant increases in iron deposition in sub-cortical 
gray matter structures, as well as myelin degeneration along the white matter skeleton, 
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were identified in MS patients. Equally relevant, the 7 T MS study itself represents the 
first use of voxel-wise morphometry in both MS white matter and sub-cortical gray 
matter using R2* and QS.  
 In the ensuing section, we identify future directions for the research documented 
in this thesis, with an emphasis on both technical developments and clinical applications. 
Two areas of technological development which have the potential for significant 
methodological advances in magnetic properties mapping-based MRI are discussed: (i) 
the use of susceptibility tensor-based white matter anisotropy assessment (4) and (ii) 
combined electric and magnetic properties brain tissue mapping (5). Refinement of these 
methodologies could result in an enhanced understanding of brain tissue compositional 
changes in vivo. This is directly applicable to quantitative monitoring of demyelination 
and remyelination in MS. In terms of clinical applications, some recent results from our 
longitudinal MS study are presented which focus on the use of susceptibility-based UHF 
MRI contrasts.    
 
6.1 Future directions: Technical Developments 
6.1.1 Susceptibility tensor-based MRI as an alternative to diffusion MRI for 
monitoring microstructure in MS 
Diffusion tensor imaging (DTI) is now a standard method for investigating the 
architecture and integrity of white matter pathways in the human central nervous system 
(6). DTI uses time-varying, pulsed magnetic field gradients applied at different 
orientations to probe the principal direction of water self-diffusion in axons (7, 8). In 
doing so, it provides in vivo information concerning pathological processes that can occur 
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in white matter. For instance, in MS, it has allowed for detection of changes in water 
diffusion directionality in both lesions and normal-appearing white matter (9-11). 
However, acquisition of DTI data places considerable demands on MRI gradient 
hardware and data interpretation is challenging. In particular, the lower SNR of DTI 
scans generally results in significantly lower spatial resolution compared to the high-
resolution, T1 or T2-weighted images conventionally used in MS diagnosis. DTI scans on 
clinical scanners use spatial resolutions of 2 - 3 mm. This is a substantial disadvantage 
when monitoring the cellular and sub-cellular environment of MS brain tissue. A larger 
voxel integrates processes from multiple biological environments, resulting in difficulty 
interpreting data. To date, high resolution DTI has only been performed: (i) in ex-vivo 
specimens (12, 13), (ii) using thick slices which sacrifice spatial resolution along the slice 
axis of the image acquisition (14) or (iii) by employing increased angular sampling (15, 
16).  
 Susceptibility-tensor imaging (STI) may offer an alternative to DTI in cases 
where high resolution and short scan time are required. STI is performed using a 
standard, short TR, gradient echo acquisition and relies on the magnetic susceptibility 
anisotropy (MSA) of white matter axons, believed to be mediated by the phospholipid 
molecules in the myelin sheath (17). A critical assumption of STI, as it pertains to white 
matter imaging of the brain, is that the principal axis of the MSA is parallel to the long 
axis of axons. With this assumption, the magnetic susceptibility tensor of white matter 
can be decomposed into three eigenvalues and their associated eigenvectors, utilizing a 
simple matrix eigenvalue decomposition (18). The corresponding eigenvalues can then be 
used to estimate susceptibility anisotropy and thus probe myelination. In addition, by 
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applying conventional line search-based tracking algorithms from DTI to the STI model,  
fiber pathways can be reconstructed. 
  Currently, only one study conducted in perfusion-fixed, mouse brains at 7 T, has 
demonstrated ST images comparable to that achieved with DTI (18). In that study, STI 
demonstrated reliable anisotropy assessment and fiber tracking in the corpus callosum, 
hippocampal commissure and anterior commissure major white matter fiber bundles. STI 
tracts appeared smoother at the edge of the fiber bundles while the major tracking 
direction was determined by the eigenvalue with the least diamagnetic susceptibility (18). 
However, the STI procedure has not been extended to human scanning. Such an 
extension would require improvements in the regularization model applied with the STI 
matrix inversion, as well as improvements to the pulse sequence and B0 shimming used 
in data acquisition.  
 Sample rotation also poses a fundamental constraint on STI reconstruction. 
Alternative methods have recently been suggested allowing either (i) STI reconstruction 
using a small number of head rotations with a cylindrically symmetric susceptibility 
tensor (CSST) (19) or (ii) STI reconstruction from a single orientation utilizing a 
multipole expansion of the image phase in terms of higher-order moments (20). During 
preliminary investigations, the protocols have shown promise but require further 
refinement from both an acquisition and mathematical analysis standpoint. 
  DTI has evolved considerably since its first demonstration nearly fifteen years 
ago by Mori et al. (7). With continued improvement in both rapid image acquisition and 
B0 shimming and the computational processing of higher-order phase data, STI-based 
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techniques (18, 19, 21) have the potential to provide significant complementary 
information to DTI fiber tracking.  
  
6.1.2 Combined magnetic and electric tissue properties mapping 
Electromagnetic properties tissue mapping (EPTM), which includes susceptibility, 
conductivity and permittivity imaging, forms the basis of a new contrast in high-field 
MRI which is uniquely sensitive to subtle changes in the microstructure of myelin and the 
concentration of ferritin iron (5, 22, 23). A more refined understanding of the 
electromagnetic properties of brain tissue, particularly how they change in pathological 
conditions such as MS, could allow for more informed diagnosis and treatment. 
Presently, work in the high-field MRI community has focused on the concise 
mathematical and computational understanding of susceptibility properties that can be 
derived from the image phase. A principal area of focus has centered around coupling 
standard gradient-echo acquisitions with advanced processing methods to isolate the 
volume magnetic susceptibility of tissue from the signal phase (17, 20, 22, 24).  
 Electric properties tissue mapping (EPTM) is an emerging related field which 
focuses on the reconstruction of images depicting both tissue conductivity (σ) and 
permittivity (ε) (25, 26). The reconstruction of quantitative conductivity maps has been 
given the acronym QCM (5). Its diagnostic utility has been cited in studies monitoring: 
(i) heart muscle viability after myocardial infarction (27), (ii) brain tissue changes in 
response to stroke (28) and (iii) differences between healthy and malignant tissue in 
cancer (29). EPTM methods are also central to MRI RF safety, particularly in high field 
MRI where heating can become a concern (25, 30).  
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 Through Maxwell’s equations, a relationship exists between the conductivity of a 
biological tissue (σ) in a strong external magnetic field under the influence of RF 
excitation and the complex-valued B1 transmit field (B1+) (25, 26, 31). Initially, it was 
believed accurate conductivity estimates were only available when using both the 
magnitude and phase of the B1+ field (31). A disadvantage of this is its requiring two 
separate scans: (i) a gradient echo, actual flip angle imaging (AFI) sequence to measure 
the magnitude of the B1+ field (32) and (ii) a spin echo sequence to sensitively measure 
the B1+ phase (31). Acquiring two separate scans in this manner lengthened the 
acquisition time and resulted in two images having different geometric and point-spread 
function-based distortions. To circumvent this difficulty, recent work has identified the 
conditions under which it is possible to reconstruct images of tissue conductivity using 
only the phase of the B1 + distribution (5, 25, 26). Assuming local transmit field 
homogeneity, the tissue conductivity can be derived from an appropriate re-arrangement 
of the Helmholtz wave equation :        
     
      [6.1]
 
where f represents a filter used to improve SNR in the conductivity map reconstruction, µ 
is permeability of the sample, ω represents the Larmor frequency of the tissue and ∠ B1+ 
is the phase of the RF transmit field (33). For a single channel, quadrature head coil, the 
phase of the B1+ field can be approximated by taking half of the phase value acquired at 
an echo time of TE = 0 (26). This is advantageous because it simplifies the solution to 
equation [6.1] and suggests that both conductivity and susceptibility can be measured in a 
single scan utilizing a multi-echo, gradient echo sequence (5).  
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 Provided the magnitude of the B1+ field is also known from AFI mapping, 
permittivity (ε) is an additional parameter that can be calculated using EPTM (26, 34). 
Although both permittivity and conductivity offer complementary information to QS 
maps, the specific relationship between these variables in human brain has not been 
explored. One significant area of interest involves the combined mapping of QCM and 
QSM in white matter fibers of the human brain. For a myelinated axon, there is an 
approximate phenomenological relation between the radius of the axon and the thickness 
of the myelin bilayer (35). If the approximate rate of conduction of an action potential 
along an axon bundle is known from QCM, it may be possible to combine this with QSM 
to estimate myelin concentration. Further, measurement of co-registered QSM and QCM 
maps with minimal image distortion would allow correction of QS maps for spurious 
conductivity-induced B1+ phase signal (5). This would result in more accurate 
determination of QS in white matter and, ultimately, more accurate determination of 
axonal myelination. 
 
6.2 Future directions: Clinical Applications 
Applying the existing magnetic properties mapping methods outlined in this thesis to 
longitudinal MS imaging and assessment of cortical demyelination patterns could 
facilitate detection of more subtle abnormalities preceding gross lesion formation and 
brain atrophy. In this section a representative preliminary analysis of serial scan data 
from our ongoing longitudinal 7 T MS study is presented. It focuses on: (i) the 
quantitative patterns of R2* and LFS changes in white matter lesions over approximately 
one year in four representative patients and (ii) the patterns of decreased pial R2* in MS 
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patients compared to age and gender-matched controls based on data from the cross-
sectional study documented in Chapter 5 of this thesis. 
6.2.1 Longitudinal Analysis of Magnetic Properties of MS White Matter Lesions 
Compared to Standard Clinical Contrasts 
A complex sequence of inflammatory and neurodegnerative processes underlies lesion 
formation in MS. The disappearance and subsequent re-appearance of white matter 
lesions on serial T2-weighted MR images of RRMS patient brain is a trademark feature 
which has been linked to clinical relapses and subsequent periods of remission. However, 
observation of lesion dynamics on serial T1 and T2-weighted MRI scans has not offered 
significant predictive power toward understanding disease progression. One possible 
explanation is that standard MRI contrasts only visualize a fraction of the disease burden 
(in both gray and white matter) which exists in MS. Standard T1 and T2-weighted 
sequences employed in clinical trials and routine follow-up assessment usually fail to 
identify transient white matter lesions. This is because, during remission phases of the 
RRMS disease, lesions on T2-weighted scans can appear isotense compared to 
surrounding normal white matter. This confounds assessment of total lesion burden.  
 An alternative to single time point lesion number or lesion volume-based 
assessment is time-series modeling of the MRI signal within a lesion. Serial MRI of MS 
patients has identified that, in the short time period (≤ 1 year) following contrast 
enhancement, distinct phases of increased and decreased signal intensity appear in 
concentric patterns around the centre of white matter lesions (36, 37). More specifically, 
Meier et al.  (37, 38) demonstrated that, for selected white matter lesions, a sigmod-
function mathematical model of two competing processes (degeneration and repair) could 
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partially explain the temporal evolution of lesions. The time-series modeling approach 
also has the potential to detect how drugs target specific phases of disease evolution, thus 
enhancing the assessment of drug treatment efficacy. 
 However, time-series modeling using standard T1 and T2-weighted clinical scans 
is non-quantitative and inherently challenging due to the presence of coil sensitivity and 
bias field offsets which can change across RF coils and MRI scanners. Moreover, it is 
very difficult to assign the signal change on T1 and T2-weighted images to specific 
inflammatory or repair processes occuring in MS at the cellular level. In this regard, the 
sensitivity of the quantitative susceptibility-based MRI contrasts to iron and myelin may 
offer an improved picture of the biological changes occuring across time within MS 
lesions (39, 40).  
 To perform a preliminary investigation of the potential of the susceptibility 
contrasts for longitudinal monitoring of lesion dynamics, serial scans taken at four 
months intervals over one year for RRMS patients enrolled in the ongoing, longitudinal 
7 T MS imaging study at the Robarts Research Institute were analyzed. The four 
contrasts employed for this analysis included two non-quantitative MRI contrasts (T1-
weighted MPRAGE and T2-weighted MP-FLAIR anatomical images), as well as two 
quantitative MRI contrasts (R2* and LFS). Seventy-six lesions were selected in four 
RRMS patients on the basis of their appearance on all four MRI contrasts for at least one 
time point in the serial images. A manual segmentation was initially performed around 
the edge of lesions on the LFS maps in each slice. The resulting binary, 2D segmentation 
masks were subsequently converted to 3D lesion masks by merging connected 
components. For each patient, all images were affine-registered to the high-resolution 
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GRE image corresponding to the patients’ most recent visit. The mean and standard error 
in R2* and LFS  of the lesions on each visit were then computed.  
 Figure 6.1 on page 128 displays the results of the above analysis. Over the full 
eight to twelve month time course for each patient, distinct changes in mean R2* and LFS 
are visible. Figure 6.1a demonstrates the results for a 46 year-old female RRMS patient 
with an EDSS score of 1.0. The reduction in R2* and positive, paramagnetic shift in the 
LFS can be interpreted as demyelination occuring over a 12 month period. All of the 
seven lesions identified for this patient followed the same pattern of steadily reduced R2* 
and increased  LFS (Note that this is LFS relative to frontal white matter). Although iron 
might be present in these lesions, iron increase would generally be coupled with 
increased R2* and this is not observed.  
 Fig. 6.1b displays imaging data taken from a 40 year-old female RRMS patient 
with an EDSS score of 1.5 and 18 uniquely identified lesions.  In the majority of lesions, 
R2* decreased during the period from zero to four months, followed by a steady increase 
to the one year time point. When coupled with the patterns seen on LFS, this result is 
interpreted as demyelination in the first four months, followed by increased iron 
deposition between four months and one year. A justification for this interpretation is the 
combined increase in R2* and the paramagnetic shift on LFS between four months and 
one year.  
 Figure 6.1c presents serial imaging data taken from a 34 year-old male RRMS 
patient with an EDSS score of 1.0. For the majority of the 26 lesions, the R2* slowly 
increased, then decreased. The local frequency shift showed a distinct increase from zero 
to four months, followed by a subsequent decrease. Such a result can be interpreted as a 
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period of remyelination from zero to four months followed by demyelination occuring 
from the four month to one year time points. 
 Fig. 6.1d demonstrates serial imaging data for a 38 year-old male RRMS patient 
with an EDSS score of 1.5. For this patient, in the majority of the 25 lesions, the mean 
LFS increased, then decreased over an eight month period. However, the R2* value in 
lesions steadily increased between zero and four months, then leveled off. This result 
suggests accumulation of iron in macrophages and glial cells around the lesion in the zero 
to four month period, followed by subsequent remyelination and a resultant diamagnetic 
shift (decrease in the relative LFS signal).  
 In Figure 6.2 on page 129, changes in lesion visibility on the four MRI contrasts 
acquired from a 38 year-old male RRMS patient with an EDSS score of 1.5 are displayed 
as serial images. Enlarged views of two selected lesions (highlighted by blue and yellow 
arrows) are shown in Figure 6.3 on page 130. Three trends are apparent: (i) diffusely 
reduced R2* and paramagnetically shifted (darker colours) LFS appear in some lesions 
prior to lesion visibility on T1 or T2-weighted scans (yellow arrows), (ii) some chronic 
lesions which are persistent across all scans on T1 and T2-weighted images show 
decreases in R2* over the 8 month time course (blue arrows), (iii) not all R2* visible 
lesions are observed on corresponding LFS maps. For instance, the lesion indicated by 
the red arrow in the R2* map is not visible on the corresponding LFS map.  
 The finding that subtle changes on R2* and LFS can precede lesion appearance on 
T1 and T2-weighted images suggests these contrasts could improve the monitoring of 
relapsing-remitting lesions. The progressive reduction in lesion R2* over the course of 
eight months, highlighted by the red arrow in Figure 6.2c, suggests that, in chronic 
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lesions where little to no dynamic changes are observed on T1 or T2 –weighted images, 
R2* may be useful for quantifying the subtle microstructural changes to myelin and 
axonal integrity that are occuring.  
 It should be underlined that this preliminary data requires further validation by 
incorporating a larger number of lesions in RRMS patients with varying EDSS scores. As 
well, due to the lack of contrast-enhanced imaging in our 7 T study, it was not possible to 
determine when a lesion first appeared. Using clinical scans acquired at the time of the 
first diagnosis for these patients may allow approximation of lesion age and improved 
stratification of white matter lesions into those which have persisted over time, those that 
have undergone transient signal intensity changes over time and those that have newly 
appeared in white matter during the course of the 7 T study. A goal for future analysis of 
the longitudinal imaging data  from the 7 T MS imaging study is to characterize the R2* 
and LFS signal changes into specific lesion types, such as transient T2 enhancing lesion, 
transient T1 black holes and chronic T1 black holes. Further research will also incorporate 
QSM analysis of both lesions and surrounding white matter. 
6.2.2 Cortical R2* Mapping in MS Patients  
Recently, there has been a surge of interest in MRI-based evaluation of cortical sub-pial 
demyelination using such quantitative techniques as magnetization transfer (41) and T2*-
based imaging (42). This interest has been fueled by the increased spatial resolution and 
improved SNR provided by high-field MRI in combination with conformal, multi-
channel receive RF coils (43). Several post-mortem studies have noted a frequent and 
wide-ranging influence of cortical demyelination in MS (44, 45). To date, however, there  
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Figure 6.1. Temporal evolution of the mean R2* and LFS signal within RRMS white 
matter lesions over the course of the first year of the longitudinal MS imaging study. 
(a) corresponds to a 46 year-old female patient with an EDSS score of 1.0. (b) 
corresponds to a 40 year-old female patient with an EDSS score of 1.5. (c) corresponds to 
a 34 year-old male patient with an EDSS score of 1.0. (d) corresponds to a 38 year-old 
male patient with an EDSS score of 1.5. 
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Figure 6.2. Representative longitudinal images from a select patient with MS. Serial 
MR images, taken at four month intervals, for a 38 year-old male RRMS patient with an 
EDSS score of 1.5. The yellow arrows point to a lesion in the sub-cortical GM which is 
detected before its subsequent appearance on T1 and T2-weighted MRI scans 8 months 
after the first scan. The blue arrows indicate a lesion in white matter which is visible on 
R2* but not on LFS.  
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Figure 6.3. Cropped and enlarged lesions as visualized by UHF MRI. These are 
enlarged views of the lesions identified with yellow and blue arrows in Figure 6.2. The 
changes in the R2* and LFS contrasts are compared to the standard T1 and T2-weighted 
clinical images. Regions of interest (lesions) are outlined in red.  
 
have been few in vivo studies examining the role of subpial demyelination across 
different brain regions.  
 Equally important, the existence of reduced R2* values in patients with MS 
compared to age and gender-matched controls has yet to be evaluated. With this in mind, 
as part of the 7 T MS imaging study, we examined localized differences in R2* of 25 MS 
patients compared to 15 controls along the cortical pial surface utilizing group-averaged 
cortical surface renderings generated in the Freesurfer software (46). Decreases in and 
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along the cortical surface are characteristic of subpial demyelination. Such changes have 
already been observed at 7 T using the magnitude signal in a small cohort of MS patients 
(47). Nevertheless, the use of R2* in cortical surface mapping and the reproducibility of 
these changes remains unclear. In our study, we evaluated cortical R2* changes to 
determine their utility in monitoring MS disease severity and staging. 
 Figure 6.4 displays statistical differences (-log10(p)) in cortical R2* of patients 
compared to age-matched controls. Statistical significance colour maps are overlaid on 
the average pial surface from all 25 patients included in the cross-sectional study outlined 
in Chapter 5. Reduced R2* in patients compared to controls is represented with blue 
colours. Areas of significantly reduced R2* along the pial surface of the cortex may 
represent regions of sub-pial demyelination. Reduced R2* is visible: (i) near the 
intersection of the post-central gyrus and superior parietal lobule (green arrows, left and 
right hemispheres), (ii) in the inferior portion of the pre-frontal cortex (pink arrow, left 
and right hemispheres) and (iii) at the interface between the superior frontal and caudal 
frontal gyri (yellow arrow, left hemisphere). Red areas indicate regions of significantly 
increased R2*, indicative of elevated iron deposition along the pial surface. Elevated R2* 
is shown in the caudal frontal sulcus of the left lateral surface (purple arrow, left 
hemisphere).  
 Cortical pathology has previously been examined utilizing high-field (7 T) MRI 
with multi-channel receive coils in a small population of MS patients (42). Cortical 
lesions were visualized and categorized into sub-types (I – IV) using high-resolution, 
multi-slice, 2D gradient echo imaging at 7 T. This work was recently extended to full 
cortical surface mapping employing the T2*-weighted magnitude signal projected onto an  
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Figure 6.4. Student’s t-test significance (-log10(p)) overlaid on the freesurfer-
generated average pial surface for the patient cohort. Significance maps are 
thresholded at a level of p < 0.1. Blue areas indicate regions of significantly reduced R2* 
for patients compared to controls. Reduced R2* is representative of sub-pial 
demyelination and is observed along the post-central gyrus, in the superior temporal lobe 
and in the pre-frontal cortex. Red areas indicate regions of significantly increased R2* 
which are indicative of increased iron deposition along the pial surface. 
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average pial surface (47).  However, the T2*-based magnitude signal varies as a function 
of receiver coil sensitivity, field strength and B1 and B0 shimming protocols (48). In our 
study, areas of significantly reduced quantitative R2*, independent of receiver coil 
technology and B1 or B0 shimming, were observed along the pial surface in brain regions 
associated with sensorimotor, memory and cognitive function. In particular, reductions in 
Figure 6.4 are seen in the motor region near the intersection of the post-central gyrus and 
superior parietal lobule (Figure 6.4, green arrows, left and right hemispheres), in the 
inferior portion of the pre-frontal cortex (Figure 6.4, pink arrow, left and right 
hemispheres) and at the inferface of the superior frontal and caudal frontal gyri (Figure 
6.4, yellow arrow, left hemisphere). These results are consistent with a previous report 
(47) of heightened T2* in the sensorimotor regions, near the left parsopercularis and in the 
superior parietal lobe.  
 In contrast to the previous study (33), however, our data showed no significant 
changes in T2* (R2*) in the lateral occipital lobe but did show R2* reductions in the pre-
frontal cortex. Such differences may reflect differences in the imaging parameters used in 
each study (2D, single-echo FLASH imaging was used by Cohen-Adad et al. with a 
resolution of 0.33 × 0.33 × 1 mm3 , while our study employed 3D, multi-echo FLASH 
with 0.5 × 0.5 × 1.25 mm3). The differences may also be characteristic of the different 
patient cohorts. Cortical mapping of R2* in a larger patient cohort combined with 
longitudinal analysis is presently underway to verify changes observed in our study and 
relate them to clinical disease status.  
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